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ABSTRACT 
 
Structural and Functional Analysis of Grapefruit Flavonol-Specific-3-O-GT Mutant P145T 
by 
Sangam Kandel 
 
This research is focused on the study of the effect of mutating proline 145 to threonine on the 
substrate and regiospecificity of flavonol specific 3-O-glucosyltransferase (Cp3GT).  While the 
mutant P145T enzyme did not glucosylate anthocyanidins, it did glucosylate flavanones and 
flavones in addition to retaining activity with flavonols. HPLC was used for product 
identification and showed mutant P145T glucosylated naringenin at the 7-OH position forming 
naringenin-7-O-glucoside and flavonols at the 3-OH position. Homology modeling and docking 
was done to predict the acceptor substrate recognition pattern and models were validated by 
experimental results. In other related work, a thrombin cleavage site was inserted into wild type 
Cp3GT and recombinant P145T enzyme between the enzyme and the C-myc tags in order to be 
able to cleave off tags.  This provides the tool needed for future efforts to crystallize these 
proteins for structural determination. 
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CHAPTER 1  
INTRODUCTION 
 
 Plants produce many compounds that are important for their growth and development. 
These products are a diverse group of chemical compounds that are produced by plants via 
various biosynthetic pathways. These compounds have been an important source of 
pharmaceuticals, insecticides, flavorings, fragrances and food colorants (Kieran et al. 1997, 
Newman and Gordon 2016 and ref. therein). Primary metabolites have important roles in the 
growth and development of plants (Ashihara et al. 2006). These include carbohydrates, proteins, 
lipids, phytosterols, acyl lipids, nucleotides, amino acids, and organic acids (Croteau et al. 2000 
and ref. therein; Ashihara et al. 2006). In addition to these primary metabolites, plants synthesize 
low molecular weight compounds called secondary metabolites that have specific functions in 
the plants in which they are synthesized. Because humans are totally dependent on plants for 
food, plant natural products and their effect in human health has been of great interest especially 
the metabolic pathways and the modification of biosynthesis in order to synthesize novel 
compounds that can be used for human benefit (McIntosh and Owens 2016 and ref. therein). 
 Several decades ago, plant secondary metabolites were considered just as waste products 
but more recent research has determined roles of many of the metabolites. Secondary metabolites 
have varied chemical structures and many different biological and ecological functions. They are 
produced from unique biosynthetic pathways from primary metabolites and intermediates. It has 
been found that secondary metabolites are important for the survival of plants as well as their 
reproductive fitness (Wink 2003; Tiwari et al. 2016 and ref. therein). Secondary metabolites have 
a key role in defense against herbivores, pests, and pathogens (Bennet and Wallsgrove 1994 and 
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ref. therein), act as insect and animal attractants for pollination and seed dispersal (Osbourn and 
Lanzeti, 2009 and ref. therein), as allelopathic agents (Weir et al. 2004), protection from harmful 
UV (Brouillard and Dangles; 1993Li et al. 1993), and nitrogen fixation in root nodules of 
legumes (Peters et al. 1986; Treuuter 2005, and ref. therein). 
Similarly, flavonoids have medicinal value in human health including anti-fungal 
(Cushnie and Lamb 2005), anti-viral (Hanasaki et al. 1994; Cushnie and Lamb 2005), anti-
bacterial (Cushnie and Lamb 2005), anti-cancer (reviewed in Benavente et al. 1997), antiallergic 
(Hope et al. 1983; Hanasaki et al. 1994; Middleton and Kandaswami 1994) and vasodilatory 
(Duarte et al. 1993) activities. In addition, flavonoids are found to inhibit lipid peroxidation 
(Salvayre et al. 1987; Ratty and Das 1998), platelet aggregation (Tzeng et al. 1991), and many 
other different pharmaceutical properties.    
Different Classes of Secondary Metabolites 
 
              Secondary metabolites are classified into different classes based on their chemical 
structure and composition, metabolic pathway by which they are synthesized, and/or their 
stability and solubility in different solvents (Owens and McIntosh 2011; Kabera et al. 2014). 
There are many different classes of secondary products the majority of which include phenolics, 
nitrogen containing compounds, and terpenoids (Harborne 1991). 
Nitrogen Containing Metabolites  
 
Alkaloids are the largest group of nitrogen containing compounds (Harborne 1991). 
These are the organic bases having a nitrogen atom as a part of their structure and usually as a 
part of their carbon cyclic system (Ziegler and Facchini 2008 and ref. therein; Cushnie et al. 
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2014 and ref. therein). Common examples of alkaloids include morphine, caffeine, and cocaine.  
Other classes of nitrogen containing metabolites include non-protein amino acids, cyanogenic 
glycosides, and glucosinolates. Because the supply of nitrogen may be limited in plants, these 
classes of secondary metabolites may be found in lower amounts or they may have restricted 
distribution in plants even in the legumes that fix atmospheric nitrogen (Harborne 1991; Cushnie 
et al. 2014 and ref. therein).      
Terpenoids 
 
Terpenoids are the most diverse and the largest family of plant secondary products 
(Harborne 1991). Terpenoids are synthesized from isopentenyl diphosphate and dimethylallyl 
diphosphate (Eisenreich et al. 2001 and ref. therein). Terpenoids are formed from acetyl 
coenzyme A via the mevalonic acid pathway (Harborne 1991), and are derived by the fusion of 
C-5 units based on isopentane skeleton (Langenheim 1994). However, the discovery of a non-
mevalonate (non-MVA) pathway changed the conventional concept of biosynthesis of terpenoids 
(Dubey et al. 2003). The non-mevalonate pathway involves biosynthesis of hemi, mono, sesqui 
and di-terpenes, as well as the phytol chain of chlorophyll and carotenoids (Dubey et al. 2003). 
Thermal decomposition of terpenoids produce the alkene gas isoprene and polymerization of 
these monomers under suitable chemical conditions can produce numerous terpenoid skeletons. 
Because of this, terpenoids are also called isoprenoids.  
Phenolics  
 
Phenolics are derived from the pentose phosphate, shikimate, and phenylpropanoid 
pathways (Harborne 1993 and ref. therein; Randhir et al. 2004). These compounds have aromatic 
structures with one or more hydroxyl groups. The majority are polyphenols in which the 
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hydroxyl groups are methyl or glycosyl substituted (Harborne 1991). Some common examples of 
phenolics include flavonoids, phenylpropanoids, xanthones, coumarins, lignans, phenols, 
stilbenoids, tannins, and quinones. Over 10,000 flavonoids exhibiting structural diversity have 
been identified in higher plants (Ferrer et al. 2008; Buer 2010 and ref. therein;   Weston and 
Mathesius 2013 and ref. therein). 
Flavonoids 
 
Flavonoids are polyphenolic low molecular weight compounds, having two aromatic 
rings, A and B, containing 6- carbon atoms that are linked by a 3-carbon chain that forms a 
closed ring or the C-ring (heterocyclic ring) containing oxygen (Fig. 1.1) (Harborne 1993 and 
ref. therein). 
 
 Fig. 1. 1 The generic structure of a flavonoid 
 
The chemical structure and orientation of various substituents determines the biochemical 
activities of flavonoids and their metabolites (Cody 1987; Harborne 1993). Flavonoids are 
ubiquitous in plants and have diverse chemical structure and properties (Harborne 1993). The 
structure of flavonoids varies widely with different substitutions such as hydrogenation, 
hydroxylation, methylation, malonylation, sulphation, methoxylation, prenylation, and 
glycosylation (Harborne 1986; Harborne 1988; Dixon and Pasinetti 2010; Owens and McIntosh 
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2011). Many flavonoids occur naturally as flavonoid glycosides (Kuhnau 1975; Havsteen 1983; 
Harborne 1993 and ref. therein; Owens and McIntosh 2009) and carbohydrate substitutions such 
as D-glucosides, L-rhamnoside, arabinosides, and galactosides (Harborne 1993 and ref. therein). 
Flavonoids are classified into different sub-groups based on the oxidation of C-15 ring system 
(Owens and McIntosh 2011 and ref. therein). Common flavonoid classes are: aurone, chalcone, 
flavanone, flavone, dihydroflavanol, flavonol, isoflavone, leucocyanidin, and anthocyanidin. 
Flavonoids possess a close structural and chemical interrelationship that reflect a close 
relationship in the biosynthetic pathways (Fig. 1.2) (Owens and McIntosh 2011 and ref. therein).  
Flavonoid Biosynthetic Pathway 
 
 Biosynthesis of flavonoids as well as other numerous plant secondary metabolites starts 
from the phenylpropanoid pathway that uses phenylalanine synthesized via the shikimate 
pathway and this has been recently reviewed (Fig 1.3; Owens and McIntosh 2011). Almost all of 
the enzymes of the phenylpropanoid pathway have been biochemically characterized and some 
of the proteins have been resolved structurally by crystallization (Yu et al. 2006). Phenylalanine 
ammonia lyase (PAL; EC 4.3.1.5), which was first characterized from Herdeum vulgare L. var. 
Aravat (barley), converts phenylalaline to trans-cinnamate (Koukol and Conn 1961). PAL 
catalyzes the elimination of ammonia and the pro-3S hydrogen to generate trans-cinnamate 
(Owens and McIntosh 2011). Cinnamate 4-hydroxylase (C4H; EC 1.14.13.11) p-hydroxylates 
trans-cinnamate to produce 4-coumarate. This enzyme requires molecular oxygen and NAPDH 
as electron donor for its activity (Potts et al. 1974; Russell 1971). The 4-coumarate is then 
activated by 4-coumarate: CoA ligase (4CL; EC 6.2.1.12) to form 4-coumaroyl–CoA through the  
15 
  
 
                                     
 
                                   
 
                               
 
                                            
 
 Fig. 1. 2 Structure and examples of some common classes of flavonoids 
Flavanol (Quercetin) 
Flavanone (Naringenin) 
Flavone (Apigenin) Dihydroflavanol (Dihydroquercetin) 
Isoflavone (Genistein) 
Anthocyanidin (Cyanidin) 
Chalcone (Naringenin chalcone) 
Aurone (Leptosidin) 
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Fig. 1. 3 Flavonoid biosynthetic pathway. PAL, phenylalanine ammonia-lyase; 4CL, 4-
coumarate: CoA ligase; CHS, Chalcone synthase; DFR, dihydroflavonol 4-reductase; CHI, 
chalcone isomerase; FSI/FS2, flavone synthase; IFR, isoflavone reductase; C4H, cinnamate-4-
hydroxylase; I2′H, isoflavone 2′-hydroxylase; FNS, Flavone synthase; F3′5′H, flavonoid 3′5′ 
hydroxylase; F3H, flavanone 3-hydroxylase; F3′H, flavonoid 3′ hydroxylase; ANS, 
anthocyanidin synthase. Hydroxytransferase can add further OH groups. (Adapted from Owens and 
McIntosh 2011). 
 
            
   
 
Cyanidin 
Luteolin 
Quercetin 
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formation of CoA esters. Mg2+ and ATP are required co-factors for enzyme activity (Ragg et al. 
1961; Hahlbrock and Grisebach 1970). 
The 4-coumaroyl-CoA is a key intermediate in phenylpropanoid metabolism in higher 
plants (Schroder et al. 1979; Hahlbrock and Scheel 1989) serving as a branch point substrate for 
biosynthesis of different metabolites, such as flavonoids, lignins, and various cinnamate esters 
(Ragg et al. 1961). 
The next step in the biosynthesis of flavonoids is the production of chalcone which serves 
as the first committed step for production of a large number of flavonoids having a common C-
15 backbone (Heller and Hahlbrock 1980; Owens and McIntosh 2011 and ref. therein). Chalcone 
synthase (CHS; EC 2.3.1.74) catalyzes the condensation of three molecules of malonyl-CoA 
with 4-coumaroyl Co-A to form chalcone (Heller and Forkmann 1988). Stereospecific 
cyclization of these bicyclic chalcones by chalcone isomerase (CHI; EC 5.5.1.6) forms the 
tricyclic flavanone which is a pre-requisite for the synthesis of the majority of downstream 
flavonoid subclasses (Moustafa and Wong 1967; Owens and McIntosh 2011 and ref. therein). 
Flavanone 3β-hydroxylase (F3H; EC 1.14.11.9) catalyzes the stereospecific 3β-hydroxylation of 
flavanones to form dihydroflavonols (Britsch et al. 1981; Britsch and Grisebach 1986). By 
introducing a double bond between C2 and C3 of a flavanone, the enzyme flavone synthase 
(FNS; EC 1.14.11.22) produces the corresponding flavone. This was first characterized in cell 
suspension cultures of parsley and was found to be encoded by a 2-oxoglutarate- dependent 
oxygenase (Sutter et al. 1975; Britsch et al. 1981; Martens et al. 2001). Flavonols are synthesized 
from dihydroflavonols catalyzed by flavonol synthase (FLS; E.C.1.14.11.23) that is also a 2-
oxoglutatarate-dependent dioxygenase requiring cofactors Fe2+ and ascorbate (Britsch et al. 
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1981; Owens and McIntosh 2011 and ref. therein). Similarly, dihydroflavonol 4-reductase (DFR; 
EC 1.1.1.219) catalyzes the stereospecific conversion of dihydroflavonols to the corresponding 
leucoanthocyanidins. This requires a cofactor, NADPH (Britsch et al. 1981; Stafford and Lester 
1982; Heller et al. 1985). Conversion of leucoanthocyanidins to anthocyanidins is catalyzed by 
anthocyanidin synthase (ANS, LDOX; EC 1.14.11.19). It is also a 2-oxoglutatarate-dependent 
dioxygenase requiring cofactors, Fe2+ and ascorbate (Saito et al. 1999).  
Hydroxytransferases further add OH groups at different positions and modify the 
compounds. Flavanone 3’-hydroxylase (F3’H; EC1.14.13.21) mediates hydroxylation of 
flavanones, flavones, dihydroflavonols, and flavonols, but is not active with anthocyanidins 
(Hagmann et al. 1983; Owens and McIntosh 2011 and references therein). Similarly, flavanone 
3’, 5’ -hydroxylase (F3’5’ H; EC 1.14.13.88) hydroxylates flavanones and dihydroflavonols 
having 4’-OH groups at 3’ and 5’ positions as well as hydroxylates 3’, 4’-OH containing 
flavanones and dihydroflavonols at 5’-OH positions (Stotz and Forkmann 1982).  
Importance of Flavonoids in Plants 
 
Flavonoids have a number of biological and ecological functions, including protection of 
plants against abiotic and biotic stresses such as UV rays and pathogen attack, signaling during 
nodulation, male fertility, and auxin transport (Mol et al. 1998; Winkle-Shirley 2002; Thill et al. 
2013 and ref. therein). Flavonoids are well known because of the accumulation of red, blue and 
purple colored anthocyanin pigments that are distributed throughout different plant tissues 
(Winkle-Shirley 2001). These colored pigments can attract insects and other seed dispersal 
agents thereby promoting plant reproduction and distribution.  
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Anthocyanins are suggested to have a role in photo protection of chlorophyll that protects 
leaves from oxidative damage and promotes the recovery of nutrients during senescence (Field et 
al. 2001; Diaz et al. 2006). The accumulation of anthocyanins can be an indication of fruit 
ripening and fruit quality (Medina-Puche et al. 2014). In Arabidopsis thaliana, accumulation of 
anthocyanins is considered as a marker of a plant’s response against adverse conditions 
unfavorable for growth and development (Chalker-Scoot 1999). Anthocyanins are accumulated 
in plants in response to abiotic and biotic stresses such as low availability of nutrients such as 
nitrogen and phosphorus (Diaz et al. 2006), pathogen attack (Lorenk-Kukula et al. 2005), 
drought (Castellarin et al. 2007), UV exposure (Kolesnikov and Zore 1957) and cold 
temperatures (Christie et al. 1994). Anthocyanins are found to accumulate in uninfected 
epidermal cells of maize plants surrounding the restricted lesions on leaves of resistant cultivar 
and it was suggested that these anthocyanins protect the healthy cells from toxic metabolites 
accumulated during the expression of resistance (Hipskind et al. 1996).  
Flavonoids can screen harmful UV radiation and protect plants from pathogen attack (Li 
et al. 1993; Kolesnikov and Zore 1957; Tanaka et al. 2008). It was shown that flavonol 
kaempferol and other phenolic compounds played important roles in vivo to protect plants from 
UV-B radiation (Li et al. 1993). The ability of flavonoids to absorb light at 280– 320 nm is 
considered to be a fundamental property to prevent DNA damage (Stapleton and Walbot 1994). 
Study of Arabidopsis mutant’s pigment analyses suggested an increase in production of UV 
absorbing compounds when exposed to UV radiation (Li et al. 1993; Bieza and Lois 2001). The 
increase in absorption in the UV region is due to an increase in flavonoid and sinapate 
accumulation (Bieza and Lois 2001). The expression of chalcone synthase (CHS) was 
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upregulated in mutants, suggesting an increase in UV blocking ability may be due to change in 
expression level of CHS genes (Bieza and Lois 2001).  
Flavonoids provide resistance to aluminum toxicity in highly acidic soil, pH <5 (Kidd et 
al. 2001). Aluminum toxicity is a major factor that may affect the productivity of crops in acidic 
soil (Barcelo and Poschenrieder 2002 and ref. therein).  Phenolics and organic acid chelates 
aluminum and detoxifies its effect (Barcelo and Poschenrieder 2002 and ref. therein). It was 
shown that in some of the aluminum resistant varieties of maize, plants that are pretreated with 
silicon exuded high levels of phenolics such as catechin and quercetin that were 15-fold higher 
than those plants not treated with silicon, suggesting that flavonoids have a significant role in Si 
induced amelioration of Al toxicity in plants (Kidd et al. 2001). This finding is consistent with 
the metal binding affinity of many flavonoids (Winkle-Shirley 2002 and ref. therein).  
Similarly, flavonoids play an important role in plant-microbe interactions. Many legumes 
have N2-fixing bacteria that helps the plant obtain nitrogen when required (Treuuter 2005 and 
ref. therein). The legume roots exude flavonoid signal molecules to attract bacteria to the root 
(Peters et al. 1986) and triggers the transcription of bacterial nodulation genes (i.e. nod, nol or 
noe genes). The protein products are required for infection that establishes the N2- fixing 
symbiosis of bacteria with leguminous plants resulting in the formation of nodules that facilitates 
the N2-fixation (Peters et al. 1986; Hungria and Stacey 1997 and ref. therein; Broughton et al. 
2003; Kobayashi et al. 2004). A few examples of flavonoids that were isolated from the 
leguminous hosts under sterile conditions are quercetin, kaempferol, naringenin, apigenin, 
daidzein, myricetin, chalcones, eriodictyol, malvidin, genistein, luteolin, and petunidin (Firmin et 
al. 1986; Peters et al. 1986; Kosslak et al. 1987; Hungria et al. 1991a; Hungria et al. 1991b; 
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Philips et al. 1992; Kobayashi et al. 2004).  Productivity of economically important legume crops 
such as soybeans, peas, lentils, lupines, and peanuts can be enhanced by inducing nodulation 
using flavonoid compounds. Even in non-leguminous plants such as wheat, flavonoids are found 
to stimulate plant-microbe interactions. Naringenin was found to stimulate the root colonization 
of wheat by Azorhizobium caulinodans and other diazotrophic bacteria (Webster et al. 1998).  
Flavonoids can also act as signaling molecules in regulating the expression of genes 
critical to phytopathogenesis (Peters and Verma 1990). Phenolic signaling molecules such as 
flavonoids mediate the transcription of virulence (vir) genes required for the transfer of T-DNA 
to host cells that results in the formation of crown galls. This was first observed in 
Agrobacterium tumefaciens (Stachel et al. 1985).  Flavonol glycosides (quercetin 3-rutinosyl-4’-
glucoside and kaempferol 3-rutinosyl-4’-glucoside) and a flavanone glucoside (dihydrowogonin 
7-glucoside) from the crude extracts of Sweet Cherry leaves were found to trigger the expression 
of a virulence gene, syrB, required for synthesis of the phytotoxin, syringomycin (Mo et al. 
1995).  
Flavonoids protect plants from ozone damage by scavenging hydroxyl radicals, free 
oxygen and hydrogen peroxide (Appel 1993; Foy et al. 1995). It was demonstrated that the ozone 
tolerance in soybean cultivars is associated with the production of kaempferol glycosides (Foy et 
al. 1995). The most sensitive transgenic lines of soybean to ozone stress were the lines without 
kaempferol glycosides (Foy et al. 1995). 
Flavonoids are found to play an important role in mediating allelopathic plant-plant 
interaction. Allelopathy is the inhibition of the growth and occurrence of one plant species due to 
chemicals secreted by another plant species (Rice 1984; Weir et al. 2004; Weston and Mathesius 
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2013 and ref. therein). The use of allelopathic compounds in agriculture may prevent the 
deterioration of environment by minimizing the use of herbicides, fungicides, and insecticides 
(Chou 1999). It was shown that Centauream aculosa (spotted knapweed) exudes the 
allelochemical (–)-catechin from its roots that inhibits the growth and seed germination of 
susceptible species such as Arabidopsis thaliana (Bais et al. 2003). Similarly, flavonoid 
aglycones formononetin, medicarpin, and kaempferol as well as glycosides of kaempferol and 
quercetin have been reported to have potential for allelopathy and autoallelopathic interactions 
(Weston and Mathesius 2013 and ref. therein). 
Flavonoids have major role in mediating plant-insect interactions (Simmonds 2003 and 
ref. therein). Polyommatus icarus, a common blue butterfly withdraws flavonoids from their 
larval host plants and use them to attract males (Burghardt et al. 2000). Resin on the surface of 
leaves of the shrub Mimulus aurantiacus Cortis contains flavonoids that protects plants by 
inhibiting the growth of Euphydryas chalcedona (Lincoln 1985; Lincoln and Wala 1986). 
Flavonoids also act as feeding deterrents and several insects are deterred by flavonoids 
(Harborne 1988 and ref. therein; Thoison et al. 2004). For example, crude water extracts of 
Japanese larch, Larix leptolepis, wood that contain higher amounts of dihydroflavonols (Yasuda 
et al. 1975) exhibited strong feeding deterrent activities against the subterranean 
termite, Coptotermes formosanus (Chen et al. 2004). Similarly, flavonoids are found to stimulate 
the oviposition of the monarch butterfly Danaus plexippus. Three quercetin galactosides; 
quercetin-3-rutinosyl, quercetin -3- B-D-glucopyranosyl (1-6) B-D-galactopyranosyl, quercetin -
3-2”,6”, alpha-L-dirhamnopyranosyl-B-D- galactopyranosyl were isolated from Ascelepias 
currassavia that stimulated oviposition of Danaus plexippus (Baur et al. 1998). 
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Flavonoids have anti-oxidant properties in plants. Reactive oxygen species, such as 
hydroxyl radicals (OH), hydrogen peroxide (H2O2), singlet oxygen (
1O2), and superoxide anions 
(O2
-) are produced and accumulated when plants are exposed to different environmental stresses 
(Asada 2006; Van Breusegem and Dat 2006). This leads to oxidative damage of different cellular 
components, such as DNA, lipids, proteins and sugars (Asada 2006; Van Breusegem and Dat 
2006). Flavonoids protect plants from these oxidative damages by scavenging free radicals 
(Agati et al. 2012 and ref. therein).  
Importance of Flavonoids in Mammals 
 
Flavonoids form an important part of the human diet and have many potential health 
impacts. Flavonoids are abundant in fruits, seeds, vegetables, and beverages, the consumption of 
which has been shown to be beneficial for human health (Quideau et al. 2011 and ref. therein). In 
humans, flavonoids are found to have anti-cancer (Benavente et al. 1997 and ref. therein; Birt et 
al. 2001; Clere et al. 2011), antibacterial (Hanasaki et al. 1994), antiviral (Hanasaki et al. 1994), 
anti-inflammatory (Chirumbolo, 2010; Gonzalez et al. 2011), antiallergic (Hope et al. 1983; 
Hanasaki et al. 1994; Middleton and Kandaswami, 1994) and vasodilatory (Duwarte et al. 1993) 
activities. 
Flavonoids are reported to possess strong antioxidant activity and free-radical-scavenging 
ability because of their capacity to donate electrons or hydrogen atoms (Robak and Gryglewski 
1988; Yuting et al. 1990; Hernandez et al. 2009). A hydroxyl group in the C-3 position, presence 
of a double bond between C-2 and C-3, a carbonyl group in C-4, and polyhydroxylation of the A 
and B aromatic rings confers ability of flavonoids to act as an anti-oxidant and free radical 
scavengers (Cook and Samman 1996). Quercetin, hesperetin, naringenin, and rutin were tested in 
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two different in vitro experimental models; Fe2+ induced linoleate peroxidation (Fe2+ -ILP) and 
auto-oxidation of rat cerebral membranes (ARCM) (Saija et al. 1995). The ability of flavonoids 
to interact with and penetrate the lipid bilayer of model membranes was studied (Saija et al. 
1995). The capacity of these flavonoids to modify free-radical-induced membrane 
lipoperoxidation is related to their ability to interact with and penetrate the lipid bilayers (Saija et 
al. 1995).  
Quercetin, a flavonol, has a number of pharmaceutical implications. It is a strong 
antioxidant which prevents oxidation of low density lipoproteins in vitro (Hollman et al. 1998). It 
has been suggested that the dietary intake of flavonols and flavones is inversely related to the 
occurrence of coronary heart disease in humans (Hollman et al. 1998). Quercetin has anti-
cancerous properties as well (Boly et al. 2011). It was found to inhibit 16 different protein 
kinases that are directly involved in controlling mitotic processes (Boly et al. 2011). Similarly, 
quercetin has been found to play a major role in prevention of neurodegenerative diseases. The 
neuroprotective effects of quercetin against H2O2-induced apoptosis in human neuronal SH-
SY5Y cells were investigated (Suematsu et al. 2011). It was found that quercetin induced the 
expression of anti-apoptotic Bcl-2 gene and repressed pro-apoptotic Bax gene in SH-SY5Y cells 
(Suematsu et al. 2011). 
More recently, the impact of flavonoids on human gut microbiota was studied and it was 
shown that an increase in the dietary uptake of fruits and vegetables containing flavonoids could 
potentially inhibit the growth of pathogenic Clostridia (Klinder et al. 2016). Flavonoids were 
shown to mediate the protective effects by interacting with gut microbiota (Klinder et al. 2016). 
Similarly, Citrus flavonoids such as hesperetin, naringenin, tangeretin, and nobiletin have been 
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reported as important therapeutics for the treatment of metabolic dysregulation (Mulvihill et al. 
2016 and ref. therein). Citrus flavonoids trigger inflammatory response in tissues of kidney, 
aorta, liver, and the adipose tissue (Mulvihill et al. 2016 and ref. therein). More recently, Citrus 
flavonoids were found to have an important role in the treatment of obesity, insulin resistance, 
dyslipidemia, atherosclerosis, and hepatic steatosis (Mulvihill et al. 2016 and ref. therein). 
Similarly, the antiviral effect of 10 different flavonoids against feline calicivirus (FCV) 
and murine norovirus (MNV) was investigated on Crandell-Reese feline kidney (CRFK) cells 
and RAW 264.7 cells and it was found that the flavonols quercetin, fisetin, and kaempferol 
inhibited FCV and MNV in a dose dependent manner (Seo et al. 2016).  Flavonoids and 
polyphenols such as catechins, proanthocyanidins, theaflavins, and flavonols were reported to 
possess anti-viral activity against influenza A and B viruses (Yang et al. 2014). 
  In a recent study of the structure–activity relationship of phenolic hydroxyls and 
alcoholic hydroxyls on the reduction of acrylamide formation by flavonoids, it was shown that 
phenolic hydroxyls contribute to reduction effects of acrylamide (Zhang et al. 2016).  As 
acrylamide is a carcinogen and genotoxin in rodents with high-dose exposure and also a 
neurotoxin in humans (Zhang et al. 2016), the acrylamide chemoprevention role of flavonoids 
clearly highlights the benefits of presence of flavonoid compounds in foods we consume.   
Flavonols and isoflavonols were found to be cytotoxic against human oral squamous cell 
carcinoma and salivary gland tumor cell lines (Sakagami et al. 1999). Some dietary flavonoids 
such as quercetin, naringin, hesperetin and catechin were reported to inhibit the replication and 
infectivity of certain RNA (Respiratory Syncytial Virus, Par influenza virus, Polio virus) and 
DNA (Herpes Simplex Virus) viruses (Kaul, 1985). In addition, flavonoids have been found to 
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inhibit lipid peroxidation (Salvayre et al. 1987; Ratty and Das, 1998), platelet aggregation 
(Tzeng et al. 1991), capillary permeability and fragility (Torel et al. 1986; Robak et al. 1987). 
Specific flavonoids act as enzyme inhibitors, hormones or immune modulators and prevent 
human diseases (reviewed in Lee et al. 2007). 
Glycosylation 
 
Glycosylation is the general term for the reactions involving the transfer of a sugar 
moiety from sugar donors to acceptor substrates including plant metabolites, phytotoxins and 
xenobiotics (Bowles et al. 2005). Many sugar donors have a sugar moiety and a UDP group 
(Owens and McIntosh 2011 and ref. therein; Sharma et al. 2014). Glycosyltransferases (GTs; EC 
2.4.1. x) constitute a large family of transferase enzymes that are involved in the biosynthesis of 
a myriad of plant metabolites such as oligosaccharides, polysaccharides or glycoconjugates 
(Taniguchi et al. 2002). Glycosylation modifies the structure and hence influences chemical 
properties and complexity (Wang 2009 and ref. therein). It enhances the solubility and stability 
through the protection of reactive nucleophile groups, thus facilitating their storage, 
accumulation, and transport, as well as regulating their bioavailability for other metabolic 
processes (Jones and Vogt 2001; Bowles et al. 2005; Gachon et al. 2005; Owens and McIntosh, 
2009; Bhat et al. 2013). Increased stability and water solubility of glycosylated products assist in 
the inactivation and detoxification of xenobiotic and harmful compounds, as well as regulation of 
hormones (Gachon et al. 2005).  
Glycosylation of flavonoids is considered to be a key mechanism in metabolic 
homeostasis of plant cells (Bowles et al. 2005).  UDP-glycosyltransferases (UGTs) catalyze the 
transfer of a glycosyl group such as glucose, galactose, xylose, rhamnose, mannose, 
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glucosamine, etc. from a nucleotide diphosphate sugar donor (UDP-sugar) to different acceptor 
substrates (Wang 2009 and ref. therein). UGTs exhibit specificity to sugar donors as well as 
acceptor molecules.  Some are highly specific to acceptor substrates that mediate glycosylation 
of only one or two types of acceptor molecules (McIntosh et al. 1990; Shao et al. 2005; Owens 
and McIntosh 2009) whereas some glycosylate a broad range of acceptor substrates (Osmani et 
al. 2009 and ref. therein).  
Plant Secondary Product Glucosyltransferase  
 
Glucosyltransferases are the soluble proteins that catalyze the transfer of a glucose 
molecule from a nucleotide-activated sugar donor, UDP-glucose, onto acceptor molecules 
resulting in the formation of glucosides (Harborne 1993 and ref. therein). Glucosylation is also 
the final step in the biosynthesis of many plant secondary metabolites (McIntosh et al. 1990 and 
ref. therein; Jones and Vogt, 2001; Devaiah et al. 2016). Among different families of GTs, the 
largest is the GT1 enzymes that use UDP-activated sugars as donor in enzymatic reactions (Vogt 
and Jones, 2000; Bowles et al. 2006; Yonekura-Sakakibara and Hanada, 2011), hence called 
uridine diphosphate glucosyltransferase (UGTs). One of the characteristic features of this family 
of GTs is the presence of a conserved motif near the carboxy-terminal (44-amino acid residues), 
known as the Plant Secondary Product Glucosyltransferase Box (Hughes and Hughes, 1994; 
Vogt and Jones 2000; Owens and McIntosh 2011 and ref. therein; Devaiah et al. 2016).  The 
residues within this signature motif have roles in forming the donor substrate binding pocket 
(Hughes and Hughes 1994; Vogt and Jones 2000; Paquette et al. 2003; Offen et al. 2006; Li et al. 
2007). In contrast, the accepter substrate binding pocket is formed within the N-terminal domain 
(Mackenzie et al. 1997; Hu and Walker, 2002; Shao et al. 2005; Offen et al. 2006; Osmani et al. 
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2009 and ref. therein). The sequences within the PSPG box are almost 60-80% similar within the 
related flavonoid GTs, however, the overall sequence similarity is fairly low (Sarkar et al. 2007; 
Owens and McIntosh 2009).   
Classification and Structure of GT Enzymes 
 
 There are two major classification systems for GTs, based on the reactions they catalyze 
according to the recommendations of the International Union of Biochemistry and Molecular 
Biology (Webb 1992) and classification based on the similarity of inferred amino acid sequence 
(Campbell et al. 1997). Based on amino acid similarity, 98 families of GTs have been defined in 
the CAZy (Carbohydrate-Active Enzymes) database (Cantarel et al. 2009; 
http://www.cazy.org/GlycosylTransferases.html). As of September 2013, the CAZy database 
reports sequence information on almost 119,910 putative GTs (Lombard et al. 2014) including 
all nucleotide sugar-dependent enzymes, glycosyltransferases that utilize sugar donors such as 
lipid diphospho-sugars, nucleoside monophospho-sugars, sugar-1-phosphates, and dolichol-
phospho-sugars (Coutinho et al. 2003) . These enzymes catalyze the O-glycosylation reaction 
and generates the phospho-containing group that departs from their corresponding activated 
sugar donors (Coutinho et al. 2003). However, this classification does not include enzymes such 
as cyclodextrin glucanotransferases (EC 2.4.1.19), dextransucrase (EC 2.4.1.5), and xyloglucan 
endotransferases (EC 2.4.1.207) (Coutinho et al. 2003) that are classified as glycosidases 
(Henrissat 1991; Henrissat and Bairoch 1993; Henrissat and Bairoch 1996; Coutinho et al. 2003). 
CAZy enzymes are classified as “inverting” or “retaining” (Fig. 1.4) based on the 
stereochemistry of the carbon atom of the sugar donor (Lairson et al. 2008 and ref. therein). 
Inverting GTs catalyze the reaction through a single nucleophilic substitution step. The acceptor 
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mediates a nucleophilic attack at C1 of the sugar donor and the configuration of the sugar is 
changed (Liu and Mushegian, 2003). Most of the inverting GTs need a divalent cation, typically 
Mg2+ or Mn2+. However, there are some metal-independent enzymes in this group as well 
(Lairson et al. 2008 and ref. therein). In the reactions catalyzed by inverting GTs, there is net 
inversion of stereochemistry of the sugar donor whereas there is net retention of stereochemistry 
of the donor substrate in the reactions catalyzed by retaining GTs (Sinnott 1990; Coutinho et al. 
2003; Lairson et al. 2008). When the nucleophile reacts with the glycosyl donor it generates a 
glycosyl-enzyme complex with inversion of stereochemistry (Lairson et al. 2008 and ref. 
therein). Then a second inversion of stereochemistry occurs after the reaction with the acceptor 
that generates the product of the reaction with a net retention of stereochemistry (Lairson et al. 
2008 and ref. therein). 
 
 
Fig. 1. 4 Inverting and retaining GTs. Catalysis of the GT enzymes via inversion or retention of 
configuration of the sugar donor (Lairson et al. 2008, Used with permission)   
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All nucleotide dependent GTs exhibit two structural folds, GT-A and GT-B (Fig. 1.5) 
(Lairson et al. 2008 and ref. therein). More recently GT-C fold have been identified (McIntosh 
and Owens 2016 and ref. therein) and these are integral membrane, and inverting N-
glucosyltransferases (Liang et al. 2015 and ref therein). The GT-A fold was first observed for 
SpsA from Bacillus subtilis (Lairson et al. 2008 and ref. therein) and GT-B for the phage T4 β-
glucosyltransferase and glycogen phosphorylase (Bourne and Henrissat 2001). 
 
 
 
 Fig. 1. 5 Structure of GT-A and GT-B folds of GTs. The GT-A represented by SpsA 
from Bacillus subtilus and (b) the GT-B fold by phage T4 β-glucosyltransferase (Lairson et al. 
2008, Used with permission)  
  GT-A and GT-B have β / α / β Rossmann-like domain (Coutinho et al. 2003; Sharma et 
al. 2013). As shown in Fig. 1.5, the fold is made up of alternating secondary structure consisting 
of β-strands and α-helices (Coutinho et al. 2003; Osmani et al. 2009 and ref. therein). In the GT-
A fold, the β / α / β secondary structure is associated tightly and abutting each other whereas in 
GT-B the structure is loosely arranged and faces each other (Coutinho et al. 2003). The GT-A 
31 
  
 
enzymes require a divalent cation such as Mg2+ or Mn2+ and have a single Rossmann domain 
(Lairson et al. 2008) whereas the GT-B fold has two Rossmann domains (Coutinho et al. 2003; 
Sharma et al. 2013). The nucleotide binding site is present on the N-terminal domain and the 
acceptor binding on the C-terminal domain of the GT-A enzymes whereas this is just opposite in 
the case of GT-B enzymes i.e. nucleotide binding on the on the C-terminal domain and acceptor 
binding on the N-terminal domain (Coutinho et al. 2003).  
Crystal Structures of Family1 GTs 
 
Crystal structures of GTs provide insight to the interactions between the enzyme’s active 
site and its acceptor and donor substrates. Crystal structures of Uridine diphosphate 
glycosyltransferases (UGTs) in complex with donor and acceptor substrates provide a basis for 
the identification of key residues that are directly involved in the enzyme function and activity 
(Offen et al. 2006).  The amino acid sequence conservation is low in GTs (Campbell et al. 1997; 
Hu and Walker 2002, Sarkar et al. 2007), even among the enzymes with established similar 
substrate and regiospecificity (McIntosh and Owens 2016 and ref. therein). However, the tertiary 
structure remains highly conserved among these GTs (Osmani et al. 2007). The study of the 3-D 
structure of protein is an important tool to compare the structure and function of GTs.  
To date, 6 crystal structures of plant secondary product family1 GTs have been solved 
(Table 1.1). All of these possess a typical GT-B fold structure, with inverting catalysis which is 
highly conserved in plant UGTs (Breton et al. 2012). Common to all of these crystallized UGTs, 
the sugar donors are bound to the C-terminal domain and the acceptors bind to the N-terminal 
domain (Li et al. 2007). The N- and C-terminal domain of these UGTs contain several strands 
(ranging from six to ten) of parallel β sheets flanked by α helices. These two domains face each 
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other and are loosely associated, and active site is formed in a cleft between these two domains 
(Osmani et al. 2009 and ref. therein). The major conformational differences between these UGTs 
are observed in their N-terminal domains, mainly in the linker region that connects the N and C-
terminal (Li et al. 2007). This is important because the active site is formed in a cleft in between 
these two domains. Similarly, in all of these UGTs, two key amino acid residues, His and Asp, 
are identified as catalytic residues. Histidine acts as Bronsted base for deprotonation of the 
acceptor molecule (Modolo et al. 2009), and an aspartate helps in stabilizing the structure after 
deprotonation (Offen et al. 2006). Table 1.1 summarizes the function of GTs whose crystal 
structures have been solved. 
 
Table 1.1 UGTs with crystal structures.  
  
UGT71G1 is a multifunctional triterpene and flavonoid glycosyltransferase from 
Medicago truncatula. Its crystal structure in complex with UDP or UDP-glucose has been solved 
(Shao et al. 2005). The crystal structure of UGT71G1 in complex with UDP-glucose suggested 
that His-22 and Asp-121 are the catalytic residues that help in deprotonation of the acceptor 
S.N GTs Function Reference 
1 UGT71G1, Medicago truncatula 
(PDB 2ACV ) 
 
Triterpenes and flavonols Shao et al. 2005 
2 VvGT1, Vitis vinifera 
(PDB 2C1Z) 
Anthocyanidins, flavonols Offen et al. 2006 
3 UGT72B1, Arabidopsis thaliana Dichloroanilines and 
trichlorophenols 
Braizer-Hicks et al. 2007 
4 UGT85H2, Medicago truncatula Flavonol, isoflavone Li et al. 2007 
5 UHT78G1, Medicago truncatula Flavonols, isoflavones, 
anthocyanidins 
Molodo et al. 2009 
6 UGT78K6, Clitoria ternatea Anthocyanidins Hiromoto et al. 2013 and 2015 
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substrate by forming an electron transfer chain within the catalytic base (Shao et al. 2005). 
UGT71G1 is involved in the glucosylation of sapogenins forming saponins, however it also 
favors kinetics with quercetin (Shao et al. 2005). The N-terminal domain is made up of seven β-
sheets flanked by eight α-helices on both sides and a small two-stranded β sheet (Shao et al. 
2005). The C-terminal domain contains a six-stranded β sheet flanked by eight α helices (Shao et 
al. 2005). UDP-binding pocket is formed in a deep cleft between two domains (Shao et al. 2005). 
Similarly, VvGT1 from Vitis vinifera glucosylates anthocyanidins but has preferred 
specificity towards flavonols such as quercetin and kaempferol (Offen et al. 2006). The crystal 
structure of VvGT1 in Michaelis complex with UDP-glucose, with acceptor substrate 
kaempferol, and in complex with UDP and quercetin has been solved. This UGT is promiscuous 
with respect to the sugar donor specificity as it can accept wide range of sugar donors such as 
UDP- glucose, UDP-xylose, UDP-mannose, UDP-galactose and UDP- N-acetyl-D-glucosamine. 
However, the activity with UDP-glucose was higher compared to other sugar donors. Three 
residues (Asp374, Gln375 and Thr141) were found to interact directly with the hydroxyl groups 
of the glucose moiety of UDP-glucose (Offen et al. 2006). 
` UGT72B1 is a bifunctional O-glucosyltransferase (OGT) and N-glucosyltransferase 
(NGT) from Arabidopsis thaliana that is involved in the O-glycosylation of trichlorophenols and 
N-glycosylation of chloroanilines (Braizer-Hicks et al. 2007). The crystal structure of 
UGT72B1was solved in a complex with the donor UDP-glucose, UDP and Tris buffer, and in 
Michaelis complex (for O-glycosyltransfer) with trichlorophenol and UDP-2- deoxy-2-fluoro 
glucose (Braizer-Hicks et al. 2007). This UGT has application in the detoxification of 
xenobiotics (Braizer-Hicks et al. 2007). 
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Similarly, UGT85H2 is a (iso) flavonoid glycosyltransferase from Medicago truncatula 
which shows activity towards kaempferol, biochanin A, and isoliquiritigenin (Li et al. 2007). 
Kinetic studies suggested that this UGT has preference and higher catalytic activity with 
flavonols than for isoflavones or chalcones (Li et al. 2007). 
UGT78G1 from Medicago truncatula is a glycosyltransferase that glycosylates 
kaempferol and myricetin (flavonols), formononetin (isoflavone), and pelargonidin and cyanidin 
(anthocyanidin) (Molodo et al. 2009). Interestingly, under certain conditions this UGT removes 
the sugar moiety from the glycosylated products (Molodo et al. 2009). The crystal structure of 
UGT78G1 was solved in complexes with UDP or with UDP and myricetin. From the crystal 
structure of UGT78G1, glutamate 192 was identified as a key residue for the glycosidase 
activity. This enzyme catalyzes the conversion of biochanin A-7-O-glucoside, genistein-7-O-
glucoside, kaempferol-3-O-glucoside, and quercetin-3-O-glucoside into the corresponding 
aglycones.  
Ct3GT-A and UGT78K6 from Clitoria ternatea catalyzes the transfer of glucose from 
UDP-glucose to anthocyanidins such as delphinidin (Hiromoto et al. 2013). The crystal structure 
of Ct3GT-A (Hiromoto et al. 2013) and the crystal structure of  UGT78K6 and its complex 
forms with anthocyanidins (delphinidin and petunidin) and with the flavonol kaempferol were 
determined (Hiromoto et al. 2015). UGT78K6 from Clitoria ternatea is anthocyanidin specific 
and had highest activity with delphinidin as acceptor. However lower relative activity (less than 
30%) were detected on pelargonidin and cyanidin and weak glucosylation activities (less than 
10%) were reported on different flavonols such as isorhamnetin, quercetin, kaempferol, and 
myricetin (Hiromoto et al. 2015) 
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The Model Plant; Citrus paradisi 
 
Citrus varieties are known to produce an array of flavonoid compounds that are present 
naturally in glycosylated form (Owens and McIntosh 2011 and ref. therein). Almost all the 
enzymes of the flavonoid biosynthetic pathway are present in Citrus. Citrus species are found to 
produce high levels of flavonoid glycosides such as flavanone, flavone, and flavonols as well as 
dihydroflavonol and chalcone glycosides (McIntosh et al. 1990; McIntosh and Mansell 1997; 
Berhow et al. 1998; Owens and McIntosh 2009; Owens and McIntosh 2011 and ref. therein). The 
most prevalent glycosylated flavonoids in Citrus are flavanone- and flavone-7-O-diglycosides 
(Owens and McIntosh 2011 and ref. therein). Flavanone-7-, flavone-7-, and flavonol-O 
glucosyltransferases were identified and partially purified from young leaves of grapefruit 
(McIntosh and Mansell 1990; McIntosh et al. 1990). Glucosyltransferases that mediate C-
glucosylation of aglycones were also reported in Citrus, but fairly in low amount (Jay et al. 
2006).  Approximately 60 different flavonoid compounds containing D-glucose and L-rhamnose 
have been reported in Citrus juices (Barreca et al. 2012).  
Grapefruit is an important cash crop as well an excellent model system to study the 
biosynthesis and metabolism of glycosylated flavonoids due to the presence of diverse groups of 
flavonoid glycosides (Owens and McIntosh 2011; Devaiah et al. 2016). A flavanone specific 
glucosyltransferase catalyzing the 7-O- glucosylation of flavanone aglycones in grapefruit 
seedlings was purified to near homogeneity and was characterized for its biochemical and kinetic 
properties (McIntosh et al. 1990). This enzyme catalyzes the transfer of sugar in the first reaction 
that synthesizes flavanone-7-O-neohesperidosides or rutinosides (McIntosh and Mansell 1990; 
McIntosh et al. 1990).  The major flavonoid found in Citrus paradisi is the bitter compound 
naringin, the 7-β-neohesperidoside of naringenin (4', 5, 7-trihydroxyflavanone) which accounts 
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for 40 to 70% of the dry weight of small green fruits (Kesteron and Hendrickson 1953; Jourdan 
et al. 1985). The quantitative distribution of naringin in different tissues and plant parts using 
radioimmunoassay showed that the young tissues of grapefruit accumulated high levels of 
naringin (Jourdan et al. 1985). The bitter taste of grapefruit is due the presence of two 
compounds, naringin and the bitter terpenoid limonin (Mansell et al. 1983). Naringin is the major 
bitter compound that imparts immediate bitterness to the grapefruit juice (Owens and McIntosh 
2011).  
Flavonol Specific 3-O-Glucosyltransferase from Grapefruit 
 
Flavonol specific 3-O-Glucosyltransferase from grapefruit is an enzyme that catalyzes the 
transfer of a glucose molecule from an activated sugar donor, UDP-Glucose, to acceptor 
substrates (flavonol aglycones) at the 3-OH position (Fig. 1.7). The products of the reaction 
catalyzed by this enzyme are flavonol glucosides (Owens and McIntosh, 2009). The recombinant 
enzyme, Cp3GT, has MW of 51.2 kDa and a pI of 6.27. This has 96% amino acid identity with a 
Citrus sinensis homologue for which direct biochemical activity was not tested (Lo Piero et al. 
2005). Cp3GT was expressed in E.coli and the recombinant enzyme was screened for activity 
with a number of different flavonoid compounds. The enzyme glucosylated only the flavonol 
aglycones quercetin, kaempferol, and myricetin. Glucosylation of flavonols occurred at 3-OH 
position and the products of the reaction were confirmed by HPLC and TLC by using standard 
compounds as ref. (Owens and McIntosh 2009). The optimum pH and temperature for this 
enzyme was 7.5 and 40-50oC, respectively. Tris–HCl buffer had pronounced effect on enzyme 
activity, with reduction of enzyme activity by 51% under optimal pH conditions. The enzyme 
was inhibited by different divalent metal ions such as Cu2+, Fe2+, and Zn2+ as well as UDP, a 
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product of the reaction. Cysteine, histidine, arginine, tryptophan, and tyrosine residues were 
identified as important amino acids for enzyme activity by the treatment of enzyme with a 
variety of amino acid modifying compounds. (Owens and McIntosh 2009).  
A large amount of insoluble recombinant protein was contained within the inclusion 
bodies when expressed in the bacterial expression system and this was completely absent when 
expressed in yeast (Devaiah et al. 2016). Expression in yeast yielded higher amounts of soluble 
protein as compared to bacterial expression systems (Devaiah et al. 2016). The substrate 
preference for flavonols, effect of metals ions, Ki value for inhibitor UDP, temperature optimum 
and temperature stability were similar for enzyme from both expression systems (Devaiah et al. 
2016). The major difference observed was the increased stability at higher pH which could be 
due to the nature and placement of tags. In the yeast expression system, the C-myc tag and 6x-
Histidin tags are present at the C- terminus whereas the thioredoxin tag and 6x-Histidine tags are 
present at the N-terminus when a bacterial expression system was used (Owens and McIntosh 
2009; Devaiah et al. 2016). 
 
 
 Fig. 1. 6 Schematic of a Cp3GT catalyzed reaction. The Cp3GT catalyzed reaction with 
quercetin as the acceptor substrate and UDP-glucose as an activated sugar donor. (Owens and 
McIntosh, 2009). 
 
 The grapefruit 3-O-glucosyltransferase enzyme glucosylates flavonol aglycones at the 3-
OH position (Owens and McIntosh, 2009) forming 3-O-glucosides. The red grape enzyme UPD-
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glucose; flavonoid 3-O-glycosyltransferase from Vitis vinifera (VvGT) glucosylates flavonols as 
well as anthocyanidins at the 3-OH position (Offen et al. 2006). VvGT shares 56% sequence 
identity and 83% homology with Cp3GT. The crystal structure of VvGT showed that threonine 
at position 141 of red grape enzyme VvGT is present on the N-terminal domain. The residues 
within the N-terminal domain are involved in forming the acceptor substrate binding pocket. 
Further it was found that threonine at this position interacts with the hydroxyl group of UDP-
glucose, the sugar donor and hence may be important in enzyme activity (Offen et al. 2006). 
Through multiple sequence alignment and 3-D modeling, the corresponding amino acid residue 
was found to be proline at position 145 of Cp3GT. Homology modeling was done to predict the 
3-D structure of Cp3GT and compared with the solved crystal structure of VvGT as template. It 
was observed that threonine 141 was closer to the substrate binding pocket of VvGT and the 
corresponding residue in Cp3GT and proline 145 was found to be closer to the substrate binding 
pocket. This modeling analysis gave an insight into prospects of substituting proline with 
threonine. Another important factor to substitute proline with threonine is the nature of these 
amino acids. Proline has a cyclic side chain that forces a bend in the structure of protein. This 
may affect the protein folding and might affect the interaction with other residues within the 
active site of the protein. Thus, we hypothesized that replacing the amino acid that imparts 
structural rigidity on the tertiary structure of a protein by a completely different type of amino 
acid may allow free rotation resulting in different orientation or may expose protein to different 
interactions resulting in a change in the structure and hence the catalytic properties of the 
enzyme.  
The main objective of the research in our lab is the structure-function study of this 
particular GT from grapefruit. Site-directed mutagenesis was performed to test hypotheses 
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regarding the substrate and regiospecificity of the flavonol specific Cp3GT. Mutated enzyme is 
biochemically characterized and the structure modelled using different computational tools. 
Experimental results are used to validate the computational models. This research is focused on 
the characterization of a mutant, P145T, and study of the effects of tags on the recombinant 
enzyme activity. 
Hypotheses 
 
This research is the continuation of the study on the structural and functional analysis of 
flavonol specific 3-O-glucosyltransferase from grapefruit. This research focused on analyzing 
the effect of a substituting proline at position 145 of Cp3GTwith threonine as well as 
characterization wild type and mutant P145T in presence and absence of tags. A thrombin 
cleavage site was inserted in both wild type and mutant P145T for the removal of the C-myc and 
6x-His tags.  
The two hypotheses of this research are: 
Hypothesis 1: Mutation of proline in Cp3GT to threonine can alter substrate specificity of 
Cp3GT.  
Hypothesis 2: Mutation of proline in Cp3GT to threonine can alter regiospecificity of Cp3GT. 
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Abstract 
 
The main objective of the research in our lab is the structural and functional analysis of 
flavonol-specific-3-O-GT from grapefruit (Cp3GT). This research has two main objectives: 1) 
Study of the effect of mutating proline to a threonine on the substrate and regiospecificity of 
Cp3GT, 2) Enzymatic characterization of wild type and mutant P145T with and without C-myc 
and 6x-His tags. The mutant P145T altered the substrate and regiospecificity, glucosylating 
flavanones and flavones along with flavonols, while the wild type glucosylated only flavonols. 
The most intriguing result was the glucosylation by P145T enzyme of flavanone and flavones. 
HPLC was used for product identification and showed mutant P145T glucosylated naringenin 
forming naringenin-7-O-glucoside. Homology modeling and molecular docking was performed 
to identify the acceptor substrate recognition patterns and models were validated by experimental 
results. Site-directed mutagenesis was performed to insert a thrombin cleavage site into the 
recombinant wild type Cp3GTand mutant P145T enzymes between the enzyme and the C-myc 
tags. This was done in preparation for future studies to crystallize the proteins and to test effect 
of tags on enzyme activity.  
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1. Introduction 
 
Flavonoids are a major group plant secondary metabolites produced as a final product of 
the phenylpropanoid pathway [1]. Over 10,000 flavonoids exhibiting structural diversity have 
been identified in higher plants [2, 3, 4]. Oxidation of the C-15 ring system is the major 
distinguishing feature for classifying flavonoids into different sub-classes [5, 6] such as flavonol, 
flavone, flavanone, iso-flavonoid, and anthocyanidin (Fig. 2.1). 
Flavonoids have been of interest to scientists for decades because of their important 
biological and ecological functions in plants. Flavonoids have important roles in photo 
protection, ability to scavenge reactive oxygen species [7], coloration of plants including flower 
pigmentation and UV-patterning [8], plant-insect interactions as feeding deterrents and 
attractants [5], mediates allelopathic plant-plant interactions that contribute to maintaining plant 
the diversity of plants, as well as enhance the agricultural productivity [4, 9] 
Flavonoid glycosides also have important roles in human health [10]. Flavonoids are 
shown to possess antioxidant properties, anti-inflammatory, anti-allergenic, anti-carcinogenic, 
anticancer, and antiviral activities, free radical scavenging capacity, coronary heart disease 
prevention, and hepatoprotective activities [11]. 
Most flavonoids are present in plants in glycosylated form. Glycosylation is mediated by 
a ubiquitous family of enzymes called glycosyltransferases. Glycosylation is an important 
reaction that modifies the structure and hence influences chemical properties and complexity of 
flavonoids [12]. 
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Fig. 2. 1 Generic structure of major classes of flavonoids and substitution patterns  
 
Glucosylation enhances the solubility and stability through the protection of reactive 
nucleophile groups, thus facilitating their storage, accumulation, and transport, as well as 
Flavone 
Luteolin: R1=R2=R5=OH; R3=R4=H 
Apigenin: R1=R3=R4=H; R2=R5=OH 
Diosmetin: R1=R5=OH; R2=OCH3; R3=R4=H 
Scutallerein: R1=R3=H; R2=R4=OH; R5=O-glu 
Flavonol 
Quercetin: R1=R2=R4=OH; R3=R5=H 
Kaempferol: R1=R3=R5=H; R2=R4=OH 
Fisetin: R1=R4=R5=H; R2=R3=OH 
Gossypetin: R1=R2=R4=R5=OH; R3=H 
 
 
Flavanone 
Naringenin: R1=R3=H; R2=R4=OH 
Hesperetin: R1=H; R2=OCH3; R3=R4=OH 
Eriodictyol: R1=R2=R4=OH; R3=H 
Isosakuranetin: R1=R3=H; R2=OCH3; R4=OH 
   
   
 
Dihydroflavonol (Dihydroquercetin) 
  
 
  
Anthocyanidin (Cyanidin) Isoflavone 
 
4’-acetoxy-7-hydroxy-6-methoxy isoflavone: 
R1=CH2COOCH3; R2= OCH3 
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regulating their bioavailability for other metabolic processes [6, 13-18]. Glucosyltransferases 
mediate glucosylation by transferring a glucose molecule from a nucleotide-activated sugar 
donor such as UDP-glucose onto acceptor molecules [15, 19]. To date, 98 families of GTs have 
been defined in CAZy (Carbohydrate-Active Enzymes) database 
(http://www.cazy.org/GlycosylTransferases.html) [20] based on the sequence identity score [21, 
22]. Out of 98 families, family 1 GTs use UDP-activated sugar as donor in the enzymatic 
reactions [14]. One of the characteristic features of family 1 GTs is the presence of a 44-amino 
acid conserved motif at the C-terminal domain, known as the Plant Secondary Product 
Glycosyltransferase Box [23, 24]. This conserved motif has a role in forming the donor substrate 
binding pocket, whereas the acceptor substrate binding pocket is formed within the N-terminal 
domain [25-29]. These are inverting GTs and have GT-B fold topology [29]. 
Plant UGTs glycosylate a large number of diverse compounds in vivo which is evident 
from the enormous variety of glycosides found in plants [13]. Some UGTs are highly specific 
and glycosylate one or a few acceptor substrates [6, 30-32], whereas others have broad 
specificity and glycosylate a wide range of acceptor substrates [33-35]. A 3-O-GT from Citrus 
paradisi (grapefruit) is specific to flavonols and glucosylates in the 3-OH position [6]. Vitis 
vinifera 3-O-GT (VvGT1) glucosylates anthocyanidin as well as the flavonol kaempferol [28]. 
These two GTs from different plants have 56% sequence identity and 87% similarity.  
Although plant UGTs have low sequence identity, they have highly similar secondary 
and tertiary structure [29]. The crystal structures of six plant UGTs have been published [27, 28, 
35-39]. All of these have conserved tertiary structure. Bioinformatics have been extensively 
tested for ability to predict the substrate and regiospecificity of GTs based on primary sequences 
by generating computational models [10, 40, 41]. However, due to insufficient information on 
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the established biochemical function of GTs, the precise function of GTs cannot be predicted 
based on primary sequence and homology modeling [10, 42]. Biochemical characterization and 
study of acceptor substrate specificity in vitro remains the most effective way to study the 
function of plant UGTs [1, 10].  
Our current research is focused on the structural and functional analysis of flavonol- 
specific Cp3GT previously characterized in our lab [6, 43]. Homology modeling, site-directed 
mutagenesis, analysis of acceptor substrate specificity and kinetic study of wild type and mutant 
Cp3GT were performed for the structure functional analysis of Cp3GT. Site directed 
mutagenesis is an effective method to identify the amino acids that are critical for enzyme 
activity and function. Multiple sequence alignment and protein homology modeling were used to 
identify the candidate residues for mutation. Both wild type Cp3GT and mutant P145T have 
been modeled using VvGT as template (Fig. 2.2). Molecular docking and modeling provides 
potential insight into the active site of the enzyme as well as basis for substrate recognition.  
For this study, Cp3GT was modeled with a flavonoid 3-O-GT from Vitis vinifera (VvGT) 
that can glucosylate both flavonols and anthocyanidins.  We identified a proline residue at 
position 145 of Cp3GT that corresponded to a threonine residue in VvGT (Fig. 2.3) and designed 
a Cp3GT-P145T mutant to test the hypothesis that that mutation of proline in Cp3GT to 
threonine could alter substrate and regiospecificity of Cp3GT. 
The gold standard of structural determination is protein crystallization. Out of six 
different crystal structures of GTs published to date, VvGT glucosylates both anthocyanidin and 
flavonols [27]. In contrast, wild type Cp3GT has strict specificity towards flavonols which is 
different from other GTs crystallized to date. None crystal structures of GTs with strict 
specificity towards flavonols have been published to date. Along with the mutant P145T, there 
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are several other mutants of Cp3GT designed at our lab that had altered substrate and 
regiospecificity [44, 45]. Crystallization of wild type Cp3GT as well as some other mutations of 
our lab possessing altered substrate and regiospecificity could be a significant contribution 
towards understanding the acceptor substrate recognition pattern of flavonol specific GTs and 
structure function study. In order to crystalize proteins, the tags should be removed. We used 
site-directed mutagenesis to insert a thrombin cleavage site into the wild type and recombinant 
mutant P145T between the enzyme and the C-myc tags in C-terminal domain in order to be able 
to remove tags.  
 
 
 
Fig. 2. 2 Structure of Cp3GT modelled with VvGT. Yellow, red, gold, and purple indicate the α-
helices, β-sheets, loops and the flexible linker region that connects N-terminal and C-terminal 
domain respectively. PSPG box is represented by black. The catalytic residues His22, Asp122, 
and Ser20 and the residue Pro145 chosen for mutation are represented by blue in the catalytic 
cleft.  
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Fig. 2. 3 Multiple sequence alignment of Cp3GT and VvGT using Biodedit. Targeted mutation is 
shown with red arrow. Proline at position 145 of Cp3GT corresponds to threonine at position 141 
of VvGT. Both of these are present within the N-terminal domain which is involved in forming 
the acceptor substrate binding pocket.  
 
Recombinant proteins are cloned with C-myc and 6x-His tags at the C-terminus for ease 
in purification and to track proteins during the purification process. Because Cp3GT does not 
have an internal thrombin cleavage site, the most effective and efficient way to cleave off tags 
from our recombinant protein was to insert a thrombin site just in between our protein and the 
tags. This permits testing of tag-effects on the recombinant proteins [6], as well as cleaving off 
tags in order to crystallize proteins.  
The recombinant enzyme Cp3GT from E.coli was tested for the effects of tag on enzyme 
activity and function [6]. The pCD1 vector harbors the thrombin site so the recombinant purified 
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enzyme which was expressed in E.coli using this vector was treated with thrombin enzyme to 
cleave off the N-terminal thioredoxin and 6x-His tags. The tags were successfully cleaved off 
after treating with thrombin enzyme [6]. To avoid the problem with inclusion bodies during 
expression and purification of recombinant protein using E.coli, Cp3GTwas expressed in yeast, 
Pichia pastoris [43]. Presence or absence of tags had no effect on enzyme activity under similar 
assay conditions when it was expressed in E.coli [6]. The substrate preference for flavonols, 
effect of metals ions, Ki value for inhibitor UDP, temperature optimum and temperature stability 
were similar in both expression system [43]. The major difference observed was the increased 
stability at higher pH which could be due to the tags. In order to test the effects of tags while 
using yeast for recombinant expression of this protein, a site-directed mutagenesis approach was 
used to insert thrombin cleavage site into the recombinant wild type and mutant P145T.  
In this study, hypothesis on the effect of mutating proline to threonine on the substrate 
and regiospecificity of Cp3GT was tested. Site-directed mutagenesis, homology modeling and 
biochemical testing of recombinant wild type Cp3GT and mutant P145T with different flavonoid 
substrates were done for structure function analysis of flavonol specific Cp3GT mutant P145T. 
In silico analysis was done to generate computational models and validated by in vitro results.  
 
2. Materials and methods 
2.1. Reagents 
 
 Quercetin, quercetin 3-O-glucoside, kaempferol 3-O-glucoside, naringenin and 
dihydroquercetin were purchased from Sigma (St. Louis, MO, USA); kaempferol, naringenin-7-
O-glucoside, hesperetin, eriodictyol, isosakuranetin, apigenin, luteolin, diosmetin, scutallerein, 
fisetin, myricetin, gossypetin, cyanidin chloride, and 4’-acetoxy-7-hydroxy-6-methoxyflavonol 
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were purchased from Indofine (Hillsborough, NJ, USA); Phenylmethylsulfonyl fluoride (PMSF) 
was purchased from MP Biomedicals (Solon, OH). Acid washed glass beads (pore size-0.5mm), 
and ethidium bromide (EtBr) were purchased from Sigma. UDP-glucose was purchased from 
Calbiochem (Gibbstown, NJ, USA); UDP-[U-14C] glucose (specific activity 293mCi/mmol) was 
from Perkin Elmer, QuikChange Site-Directed Mutagenesis kit was purchased from Agilent 
Technologies, Inc. (Santa Clara, CA), GeneJET plasmid mini-prep kit was purchased from 
Thermo scientific, Wizard Plus Midipreps DNA purification System was purchased from 
Promega, restriction enzymes SacI and DpnI were purchased from Promega (Madison, WI), all 
other reagents were purchased from Fisher Scientific. 
2.2. Scale up expression of recombinant wild type Cp3GT and mutant P145T 
  
  A 3mL aliquot of YPD media containing 100 µg/mL zeocin was inoculated with 
glycerol stock of yeast cells containing wild type Cp3GT or mutant P145T stored at -80°C and 
incubated overnight (16-18hrs) at 30°C at 250 rpm. A 500µL of overnight culture was 
transferred to a 1L flask containing 250mL of BMGY and incubated at 30°C, 250 rpm to an 
O.D.600 of 2-6. The overnight culture was transferred to different 50mL centrifuge tubes and 
pellets were collected by centrifuging for 5 minutes at 2800 x g at room temperature and washed 
with 50mL of BMMY by suspending the cell pellets. The cell pellets were washed twice with 
BMMY media to remove glycerol. The washed cell pellets were resuspended in 250ml of freshly 
prepared BMMY in 1L baffled flask and incubated for 24hrs at 30°C at 250 rpm. After 24hrs 
(optimum time from time course induction study and western blot analysis), the overnight culture 
was transferred to different 50mL centrifuge tubes and cells were harvested by centrifuging for 5 
minutes at 2800 x g at room temperature and stored at -80°C.  
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2.3. Protein extraction and purification 
 
The cell pellets stored at -80°C were resuspended in 5-10 mL of breaking buffer (50mM 
sodium phosphate buffer at pH 7.5, 1mM EDTA, 5% glycerol) containing 5 mM βME and 1 mM 
PMSF. Cells were lysed using French press at 1120 psi pressure. The cells were put in ice during 
entire lysis process. Before using French press, it was first washed with distilled water and rinsed 
with breaking buffer twice to ensure it was free from other proteins. Lysis was repeated for at 
least 4 cycles ensuring the yeast cells were broken efficiently. The lysed cells were centrifuged at 
13,000 x g for 20 minutes at 4 °C and the supernatant was collected and kept on ice.  
PD-10 columns for buffer exchange were equilibrated with 25mL equilibration buffer (50 
mM sodium phosphate buffer at pH 7.5, 300 mM sodium chloride) containing 5mM βME. A 2.5 
mL volume of the crude protein was subjected to buffer exchange with PD-10 column and the 
flow through the PD-10 was discarded. A 3.5mL volume of the equilibration buffer was used to 
elute the protein from PD-10 column. The PD-10 column was again equilibrated and the 
remaining crude protein was eluted with 3.5mL of equilibration buffer as described. A 2mL bed 
volume TALONR IMAC cobalt metal affinity resin column was equilibrated with 25mL of 
equilibration buffer containing 5mM βME prior to use. The 7.5mL of eluted protein from the 
PD-10 column was loaded on a 2mL bed volume TALONR IMAC cobalt metal affinity resin 
column at a flow rate of 0.5 mL min−1 and discarded the flow through. The column was washed 
with equilibration buffer until the O.D.280 of the eluate reached almost zero. Equilibration buffer 
was used as blank to measure the O.D. of the washed fractions. Once all the non-specific 
proteins were washed off from the column, the bound protein was eluted in 2 mL fractions with 
elution buffer (50 mM sodium phosphate buffer pH 7.5, 300 mM sodium chloride, 5 mM βME, 
51 
  
 
and 150 mM imidazole). The protein concentration of each eluted fraction was estimated using 
Nanodrop at 280nm. The fractions with higher concentrations of proteins were pooled, 
concentrated, and desalted using Amicon Centricon 30 MWCO centrifugal filters (Millipore, 
Billerica, MA, USA) by centrifuging at 2800 x g at 4°C for 10 to 30min until the volume reached 
500µL. After the volume reached 500µL, 2mL of assay buffer (50 mM sodium phosphate buffer 
pH 7.5, 14 mM βME) was added in the Amicon Centricon Centrifugal Filter and centrifuged 
again to remove the imidazole that was used for elution. The concentrated protein was collected 
and concentration was measured and kept on ice for further assay and biochemical testing. A 
50µL aliquot of each protein fraction from desalting, flow through, washing, and elution were 
collected for western blot analysis.  
2.4. Glucosyltrasnferase activity 
 
 Glucosyltransferase activity was assayed by determining the incorporation of 14C-glucose 
into the reaction product [6, 29]. For initial screening, reactions were performed using 0.025 µCi 
of UDP-[U-14C] glucose (specific activity of 263mCi/mmol) diluted to 20,000cpm/10uL in 
water. Each reaction for activity screening was a 75µL reaction mixture containing 5 µL of 
flavonoid aglycone (50nmol/5µL) in ethylene glycol monomethyl ether, 10 µL of sugar donor 
(UDP-14C glucose), 50 µL of 50mM phosphate buffer (pH 7.5) containing 14 mM βME, and 
10µL of recombinant enzyme (3µg/10µL). The reactions were incubated in a 37oC water bath for 
5 minutes. The reactions were terminated by the addition of 15 µL of 6 M HCl. The product of 
the reaction was then extracted using 250 µL of EtOAc and vigorous mixing, and centrifuging 
for few seconds. A 150 µL aliquot of the EtOAc extract was placed in 2 mL of CytoScint 
scintillation cocktail (Thermo Fisher) and incorporation measured by a Beckman LS 6500 
scintillation counter.  
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For other biochemical analysis and kinetics, each standard 75µL reaction contained 5µL 
of flavonoid aglycone (50nmol/5µL) in ethylene glycol monomethyl ether, 50 µL of 50mM 
phosphate buffer (pH 7.5) containing 14 mM βME, 10µL UDP-glucose (100nmol/10µL) having 
50,000cpm/10µL, and 10µL of 0.5µg/10µL enzyme (linearity obtained with 0.5µg of enzyme), 
The reactions were incubated at 37 °C for 10 minutes unless otherwise described. The reactions 
were terminated by the addition of 15 µL of 6 M HCl. The products of the reaction was then 
extracted using 250 µL of EtOAc and vigorous mixing, and spinning for few seconds. A 150 µL 
aliquot of the EtOAc extract was placed in 2 mL of CytoScint scintillation cocktail (Thermo 
Fisher) and incorporation measured by a Beckman LS 6500 scintillation counter. Incorporation 
of the radioactive glucose in the reaction product was calculated by multiplying cpm measured 
with 1.67 to obtain total cpm incorporated. Nanomoles of products are determined by cpm 
incorporated divided by 500. 
2.5.Product identification 
 
  The standard 150µL reaction for product identification contained 10µL of aglycone 
(100nmols/10µL) in ethylene glycol monomethyl ether, 100 µL of 50mM phosphate buffer (pH 
7.5) containing 14 mM βME, 20µL of non-radioactive UDP-glucose (200nmol/20µL), and 20 µL 
of enzyme (6-10µg). The reactions were incubated for 30-60 minutes at 37oC to ensure sufficient 
product formation for analysis. The reactions were terminated by the addition of 15 µL of 6 M 
HCl. The products were extracted using 500 µL of ethyl acetate and dried under a stream of N2. 
The residues were resuspended in HPLC grade methanol (60 µL) and 10 µL injected for 
reversed-phase HPLC analysis on a Waters Breeze HPLC system composed of an in-line 
degasser AF, a binary HPLC pump 1525, and a dual λ absorbance detector 2487 operated by 
Breeze software version 3.30 (Waters, Milford, MA, USA). Samples were fractionated at room 
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temperature using a Bridge C18, 4.6 × 150 mm column at a flow rate of 1.0 mL min−1. 
Fractionation was achieved with HOAc/H2O (15:85) as the mobile phase and a linear gradient of 
HPLC grade CH3CN (5−65%) over 25 min as the organic phase. Chromatograms were detected 
at A290 and A365 for analysis of the product of the reaction. Retention time of reaction products 
were compared with authentic standards. 
2.6. Homology modeling and docking 
 
 Homology modeling was performed using the solved crystal structure of the Vitis vinifera 
flavonoid-3-O-glucosyltransferase as template (Offen et al. 2006). UCSF Chimera 
(https://www.cgl.ucsf.edu/chimera/) was used to generate the 3-D structure of protein. 
EasyModeller 4.0 [46] was used to generate models having different molpdf (molecular 
probability distribution), DOPE (Discrete Optimized Protein Energy) and GA341 scores. The 
model with lowest DOPE score was considered as best fit model [46] and was used for further 
docking analysis. The model was refined by energy minimization for molecular docking by 
selecting all the residues using Swiss PDB viewer (http://spdbv.vital-it.ch/).  This generates the 
energy minimized model to the most stable state. The best model was superimposed with the 
template to check similarities and differences in the structure among loop as well as α-helix and 
β-sheets using Chimera. This energy minimized model was used with PyRx 
(http://pyrx.sourceforge.net/) to dock the protein with various ligands of choice. The protein 
model generated by Swiss PDB viewer and a reference ligand (different flavonoid aglycones, 
downloaded from PDB database) was added in the system before running docking program 
(PyRx). Then the models were analyzed using Autodock 1.5.6 of MGL tools software 
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(autodock.scripps.edu). When model with lowest DOPE score did not agree with experimental 
results, additional models were examined.  
2.7.Insertion of thrombin site 
2.7.1. Primer design 
 
 Thrombin recognizes the consensus sequence leucine-valine-proline-arginine-glycine-
serine, cleaving the peptide bond between arginine and glycine. Primers specific for thrombin 
site were designed (Supplementary Table B.1) using Quickchange Primer Design web tool from 
Agilent Technologies. 
(http://www.genomics.agilent.com/primerDesignProgram.jsp?&_requestid=994370). Site-
directed mutagenesis PCR was performed to insert the thrombin site between the wild type 
Cp3GT and mutant P145T enzymes and the C-myc tags.  
2.7.2. Site-directed mutagenesis 
 
 Site-directed mutagenesis PCR was performed to insert thrombin site in between the wild 
type Cp3GT and mutant P145T enzyme and the C-myc tags using QuikChangeR Lightning Site- 
Directed Mutagenesis Kit from Agilent Technologies. The reaction mixture contained: 
P145T-thrombin cleavage site 
5µL of 10X reaction buffer  
1.25µL of 125ng/µL Primer (forward)  
1.25µL of 125ng/µL Primer (reverse) 
1µL of dNTP mix 
1.5µL of Quick solution reagent 
1 µL of Quick change DNA polymerase enzyme 
39µL of P145T DNA template (45ng) 
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Cp3GT-thrombin cleavage site 
5µL of 10X reaction buffer  
1.25µL of 125ng/µL Primer (forward)  
1.25µL of 125ng/µL Primer (reverse)  
1µL of dNTP mix 
1.5µL of Quick solution reagent 
1 µL of Quick change DNA polymerase enzyme 
39µL of Cp3GT DNA template (35ng)  
 
 PCR was run using the following conditions as mentioned on the QuikChangeR Lightning 
Site- Directed Mutagenesis Protocol from Agilent Technologies.  
Table 2. 2 PCR conditions for insertion of thrombin site using site directed mutagenesis. 
 
 
 
 
 
2.7.3. Heterologous expression  
 
The site directed mutagenesis PCR product was treated with the restriction enzyme DpnI 
(Agilent Technologies) to digest the parental template DNA (Supplementary Fig. C.3) and the 
wild type Cp3GT and mutant P145T plasmid with thrombin site was transformed into Top 10 
competent E.coli cells (Invitrogen) by the heat shock method. The transformants were grown on 
low-salt LB plates containing 25µg/mL zeocin and incubated at 37 °C. Positive colonies were 
Step Temperature (
O
C) Time(s) Cycles 
Initiation 95 30 1 
Denaturation 95 30 16 
Annealing 55 60 
Elongation 68 600 
Extension 68 600 1 
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identified by colony-PCR using vector specific AOX primers (Fig 2.21) and restreaked on low-
salt LB plates containing 25µg/mL zeocin and incubated at 37 °C. Plasmids were extracted using 
Quantum PrepTM Plasmid Miniprep Kit (Invitrogen) and the presence of the thrombin site in-
frame was confirmed by sequencing (Fig. 2.22-2.23). Plasmid were extracted using Quantum 
PrepTM Plasmid Midiprep Kit (Invitrogen) and linearized using SacI  enzyme (Promega) to 
transform into competent Pichia pastoris (Mut+) cells by electroporation. Transformation into 
yeast is in progress.  
 
3. Results and discussion 
 
3.1. Acceptor substrate specificity 
 
The purified wild type Cp3GT and mutant P145T activities were screened with 15 
different aglycone substrates belonging to six different flavonoid subclasses (Table 2.1). Wild 
type Cp3GT is flavonol specific and adds sugar at 3-OH only and it glucosylates quercetin to the 
highest degree (Owens and McIntosh, 2009). In addition to glucosylating flavonols, the mutant 
P145T glucosylated flavones and flavanones in the screening assay (Table 2.1). This is 
significant because flavanones and flavones do not contain a 3-OH group for glucosylation. In 
contrast to the wild type Cp3GT enzyme, the mutant P145T enzyme had 2X higher level of 
activity with kaempferol as a substrate.  In the screening assay, wild type Cp3GT had no activity 
with flavonoid substrates other than flavonols (Owens and McIntosh 2009).  However, mutant 
P145T had activity with naringenin, hesperetin and scutallerein (Table 2.1).  
These results suggest that the mutant P145T substrate specificity was broadened to accept 
different classes of flavonoids as well as regiospecificity in terms of attaching the sugar at 
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different hydroxyl positions. Because this is a hypersensitive assay and it might give false 
positive results, results need confirmation by kinetic assay.  
3.2. Product identification 
 
High Performance Liquid Chromatography (HPLC) was performed to identify the 
products of the reaction catalyzed by the mutant P145T as in Owens and McIntosh, 2009. 
Additionally, product identification verified the activity screening results. Retention times of the 
reaction products were compared with those of standard compounds to identify the products of 
the reaction using quercetin, kaempferol and naringenin as acceptor substrates. The products of 
the reaction were quercetin-3-O-glucoside (Fig. 2.4), kaempferol-3-O-glucoside (Fig. 2.5) and 
naringenin-7-O-glucoside (Fig. 2.6) with quercetin, kaempferol and naringenin as acceptor 
substrate, respectively. As has been previously observed [6, 42], naringenin was not glucosylated 
by wild type Cp3GT.  
The mutant P145T glucosylated quercetin at the 3-OH group forming quercetin-3-O-
glucoside. Similarly, the mutant P145T glucosylated kaempferol at the 3-OH position forming 
kaempferol-3-O-glucoside. Naringenin does not contain a 3-OH group for glucosylation. 
However, HPLC chromatograms showed that the mutant P145T enzyme glucosylated naringenin 
at the 7-OH group forming prunin. No glucoside peak was obtained for the reaction catalyzed by 
wild type Cp3GT using naringenin as acceptor substrate. These results suggested that mutant 
P145T had broadened substrate and regiospecificity of Cp3GT and also confirmed the initial 
screening assay. These results indicate that a single point mutation altered the substrate and 
regiospecificity of Cp3GT. This might be due to the structural change in the protein caused by a 
single mutation that caused an alteration in the activity and functioning of the mutant protein.  
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Table 2. 1 Activity Screening of Wild Type Cp3GT and Mutant P145T.  
Activity results of each acceptor substrates are expressed as percentage relative activity with 
respect to glucosylation of quercetin by wild type enzyme. 
Flavonoid 
subclass 
Flavonoid substrate Base Structure Relative activity 
WT P145T 
Flavonol Quercetin: R1=R2=R4=OH; 
R3=R5=H 
 
100 90 
Kaempferol: R1=R3=R5=H; 
R2=R4=OH 
52.5 119 
Fisetin: RA=R4=R5=H; 
R2=R3=OH 
42 54 
GossypetinR1=R2=R4=R5=OH; 
R3=H 
25 42.5 
Dihydroflavonol Dihydroquercetin 
 
 
 
* * 
Flavanone Naringenin: R1=R3=H; 
R2=R4=OH 
 
9 25 
Hesperetin: R1=H; R2=OCH3; 
R3=R4=OH 
6.5 34 
Eriodictyol: R1=R2=R4=OH; 
R3=H 
2 5 
Isosakuranetin: R1=R3=H; 
R2=OCH3; R4=OH 
8 6 
Flavone Luteolin: R1=R2=R5=OH; 
R3=R4=H 
 
1 7 
Apigenin: R1=R3=R4=H; 
R2=R5=OH 
1 2.5 
Diosmetin: R1=R5=OH; 
R2=OCH3; R3=R4=H 
5.5 12 
Scutallerein: R1=R3=H; 
R2=R4=OH; R5=O-glu 
11.5 33 
Isoflavone 4’-acetoxy-7-hydroxy-6-
methoxy isoflavone 
R1=COOH; R2= OCH3 
 
 
6.5 10.5 
Anthocyanidin Cyanidin chloride 
 
 
1.5 4.5 
*Needs confirmation by a regular assay 
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Fig. 2. 4 Reaction product identification of mutant P145T with acceptor quercetin. HPLC 
chromatograms of A) standard quercetin-3-O-glucoside, retention time 8.6 minutes, B) standard 
quercetin, retention time 11.6 minutes, and C) products of the reaction catalyzed by recombinant 
mutant P145T. Retention times (minutes) are indicated by the peaks. 
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Fig. 2. 5 Reaction product identification of mutant P145T with acceptor kaempferol. HPLC 
chromatograms of A) Standard kaempferol-3-O-glucoside, retention time 9.6 minutes, and 
standard kaempferol, retention time 13.1 minutes, and B) the products of the reaction catalyzed 
by recombinant mutant P145T. Retention times (minutes) are indicated by the peaks.  
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Fig. 2. 6 Reaction product identification with acceptor naringenin. HPLC chromatograms of A) 
naringenin 7-O-glucoside standard, retention time 9.5 minutes, B) naringenin standard, retention 
time 12.2 minutes, C) reaction products catalyzed by mutant P145T, and D) reaction products 
catalyzed by wild type Cp3GT enzyme. Retention times (minutes) are indicated by the peaks. 
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 Homology modeling and molecular docking were performed to provide insight into 
possible structural changes brought about by the P145T mutation.                                                                                                                              
3.3. Enzyme characterization 
 
 Wild type and mutant P145T were characterized using quercetin and kaempferol as 
acceptor substrates. Wild type had higher percentage relative activity with quercetin although 
glucosylates kaempferol whereas the mutant P145T had higher percentage relative activity with 
kaempferol although it glucosylates quercetin as well (Table 2.1).  
3.3.1. Optimal reaction condition 
 
3.3.1.1. Enzyme concentration 
 
 Three different concentrations of enzymes were taken for reaction to test the effect of 
enzyme concentration on the rate of reaction. The reaction mixture was incubated at 37oC at 
different time intervals from 0, 10, 20, 30, 60 and 90 minutes. With 0.25 µg of enzyme, the 
reaction was linear for 15 minutes for both wildtype and mutant enzyme with quercetin. 
Similarly, the reaction was linear for 15 minutes with 0.5 µg of enzyme for both wild type and 
mutant P145T enzyme with kaempferol.  For subsequent kinetic analyses with quercetin, 0.25 µg 
of enzyme was used to incubate reaction mixture for 10 minutes and with kaempferol 0.5 µg of 
enzyme was incubated for 10 minutes.  
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Fig. 2. 7 Time course study with different concentration of enzyme with quercetin. A) WT- wild 
type Cp3GT, B) mutant 145T. The reactions were linear for 15 minutes with 0.25 µg enzyme for 
both wild type Cp3GT and mutant P145T.  
 
Activity screening results suggested that the wild type Cp3GT and mutant P145T had 
almost similar activity (Table 2.1) that needed further confirmation by a regular assay. The 
pmoles of UPD-glucose incorporated into the reaction product after incubating 0.25 µg of wild 
type Cp3GT for 30 minutes (Fig. 2.7, A) was almost equal to the pmoles of UDP-glucose 
incorporated into the reaction product after incubating 0.25 µg of mutant P145T for 30 minutes 
(Fig. 2.7, B). As a time course study is a regular biochemical assay, this confirmed the activity 
screening results with quercetin for both wild type Cp3GT and mutant P145T.  
 Time course study with kaempferol further confirmed activity screening assay for 
kaempferol. The mutant had almost 119% relative activity with kaempferol whereas wild type 
Cp3GT had almost 53% relative activity (Table 2.1). The time course study showed that the 
pmoles of UDP-glucose incorporated into the reaction product after incubating 0.5 µg of mutant 
P145T for 30 minutes is two times higher than the pmoles of UDP-glucose incorporated into the 
reaction product after incubating 0.5 µg of wild type Cp3GT enzyme. This suggests that an 
 A  B 
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increase in the activity of mutant P145T is due to the structural change brought about by a single 
point mutation.  
 
  
  
Fig. 2. 8 Time course study with different concentration of enzyme with kaempferol. A) WT- 
wild type Cp3GT, B) mutant 145T. The reactions were linear for 15 minutes with 0.5 µg enzyme 
for both wild type Cp3GT and mutant P145T.  
  
3.3.1.2. Optimal temperature 
 
The optimal reaction temperatures for wildtype and mutant P145T were determined by 
incubating the reaction mixture at different temperatures; 20, 30, 40, 50, 60, 70, and 80 oC 
 
 A  B 
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Fig. 2. 9 Effect of temperature on enzyme activity with quercetin. A reaction mixture of 75 µL 
was incubated for 10 minutes at different temperatures with 0.25 µg of enzyme. The optimum 
temperature for wild type Cp3GT was 30oC and for mutant 1-point peak was obtained for P145T 
at 60oC. 
  
 
 
 Fig. 2. 10 Effect of temperature on enzyme activity with kaempferol. A reaction mixture of 75 
µL was incubated for 10 minutes at different temperatures with 0.5 µg of enzyme. The mutant 
P145T had optimal activity at 50-60oC whereas wild type Cp3GT had almost a brood maximal 
activity from 30-50oC. 
A) Quercetin 
Incubation temperature (oC) 
B) Kaempferol 
Incubation temperature (oC) 
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A sharp peak was obtained for mutant P145T at 60oC with both quercetin and kaempferol 
as acceptor substrate. These results need to be confirmed as one sharp peak was observed at 
60oC. The optimum temperature of wild type Cp3GT with quercetin was found to be 30oC as 
reported earlier [6], whereas the wild type enzyme showed almost constant activity from 30 oC to 
50oC with kaempferol. The higher optimum temperature of mutant P145T could be due to single 
point mutation from proline to threonine that caused a change in the structure of the mutant 
P145T protein. Proline restricts the free rotation of the protein due to its cyclic side chain thereby 
affecting the interactions with other residues. However, as threonine has free side chains that 
might allow protein to rotate freely and involve in non-covalent interactions with other residues 
at the active side. This might cause a change in the structure of protein.  
Activity screening suggested that mutant P145T had almost 2X higher relative activity 
with kaempferol (Table 2.1). The activity of mutant P145T was confirmed by the time course 
study (Fig. 2.10). This needs further confirmation with detailed kinetic study of the activity. 
3.4. Structural similarities and differences between wild type Cp3GTand P145T. 
 
The 3-D structure of a protein gives an insight toward residues critical for the functioning 
of the protein as well as the residues that are present within the active site. The recombinant 
mutant P145T and wild type Cp3GT protein was modeled with Vitis vinifera 3-O-GT. VvGT 
glucosylates both flavonols and anthocyanidins [27]. It has 56% sequence identify and 83% 
homology with Cp3GT. Homology modeling was performed to predict the 3-D structure of 
recombinant wild type Cp3OGT and mutant P145T using different computational tools. 
Comparison of the 3-D structures with the crystal structure of VvGT reveals conserved 3-D 
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structures. Despite having 83% sequence similarity and 56% identity, Cp3GT and VvGT have 
similar 3-D structure. However, some differences in the structure were apparent (Fig. 2.12). 
A. 
 
B. 
 
Fig. 2. 11 Homology modeling of mutant P145T with VvGT. A) Predicted tertiary structure of 
mutant P145T, and B) Tertiary structure of VvGT. Red represents the β-strands, yellow 
represents the α-helices, black represents the PSPG box, and purple represents the flexible linker 
that connects N-terminal and C-terminal domain. Structures generated using Chimera1.3 
(https://www.cgl.ucsf.edu/chimera/).  
68 
  
 
The tertiary structure of wild type Cp3GT and mutant P145T are made up of α-helices, β-
strands and coils and is globally similar with tertiary structure of VvGT (Fig. 2.2, 2.11). Like all 
other GTs of Family 1, the wild type Cp3GT and mutant P145T models showed a common GT-
B fold topology that consisted of the two Rossmann- like domains that faced each other linked 
by a flexible linker region. The N-terminal region consisted of seven β-strands facing towards 
the catalytic cleft and the C-terminal domain had six β-strands. These secondary structures faced 
each other towards the center of the catalytic cleft. The predicted active site is formed in a cleft 
between the N-terminal domain and C-terminal domain linked by a flexible loop (Leu 254 to Gly 
271). The PSPG box at the C-terminal domain had conserved amino acid residues that extend 
from tryptophan 345 to arginine 389. 
 Comparison of the 3-D model structure of wild type Cp3GT and mutant P145T 
has revealed several structural similarities and differences (Fig. 2.12). The overall 3-D structure 
of wild type Cp3GT and the mutant P145T is conserved. A difference in the structure due to a 
change in single amino acid is seen in the catalytic cleft shown by the red circle (Fig. 2.12 B and 
C). Acceptor and donor substrate binding pocket is formed in the cleft between N-terminal and 
C-terminal domain. The loop region (Leu254 to Gly271) as represented by purple color (Fig. 
2.12) connects the N-terminal and C-terminal domains. A difference was observed in the 
position of the loop region in all of the predicted structures. Other differences in the orientation 
of helices and loops are indicated by arrows. These models suggested that a mutation of proline 
to threonine is causing structural change in the tertiary structure of protein. As proline’s side 
chain restricts the rotation of the protein, substituting proline to threonine brought structural 
change in the protein model. This structural change might be the cause of altered substrate and 
regiospecificity as observed in experimental results.  
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Fig. 2. 12 Structural similarities and differences. A) VvGT, B) wild type Cp3GT, and C) mutant 
P145T generated using EasyModeller by using VvGT as template. Differences were observed in 
the catalytic cleft that forms active site for the substrates. Red arrow and red circle indicate 
differences; black arrow indicates similarities. Differences were also observed in the loop region 
that connects the N-terminus and C-terminus.  
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Fig. 2. 13 Superimposition of VvGT and Cp3GT. The 3-D structure of VvGT and Cp3GT is 
highly conserved. The red arrow/circle shows the significant differences seen in the modeled 
structures.   
The superimposition of Cp3GT and VvGT also shows a somewhat conserved 3-D 
structure with some key differences (Fig. 2.13). The most significant difference observed was at 
the catalytic cleft that is formed between the N-terminal and C-terminal domain as shown by red 
circle. Another major difference observed was on the loop region. The flexible loop region 
connects the C-terminal and N-terminal domain and the catalytic site is formed in a cleft between 
the N-terminal and C-terminal domain. This difference observed between wild type Cp3GT and 
VvGT might contribute to different acceptor recognition pattern as VvGT glucosylates 
anthocyanidins and flavonols whereas Cp3GT glucosylates flavonols only.  
The conservation of overall 3-D structures of these models, yet differences in substrate 
specificity, need a more rigorous analysis to resolve. Therefore, further in silico analyses were 
performed by models docking with potential substrates (Fig.2.14- 2.19). 
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Fig. 2. 14 Docking of wild type Cp3GT and mutant P145T with naringenin. A) Wild type 
Cp3GT and B) Mutant P145T docked with Naringenin. The red arrows and the circle indicate a 
major difference observed in the structure of wild type Cp3GT and mutant P145T.  
 
  
 
 
 
Fig. 2. 15 Docking of wild type Cp3GT and mutant P145T with quercetin. A) Wild type Cp3GT 
and B) Mutant P145T docked with quercetin. The red arrows and the circle indicate a major 
difference observed in the structure of wild type Cp3GT and mutant P145T. 
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Fig. 2. 16 Docking of wild type Cp3GT and mutant P145T with kaempferol. A) Wild type 
Cp3GT and B) Mutant P145T docked with kaempferol. The arrows and circle represent the 
major differences observed between the wild type Cp3GT and the mutant P145T when docked 
with kaempferol.  
The model structures of wild type Cp3GT and mutant P145T docked with different 
acceptor substrates revealed many similarities and differences. One significant difference was on 
the catalytic cleft formed between the N-terminal domain and the C-terminal domain, and the 
loop region that connects the N-terminal and C-terminal domains (Fig. 2.14-2.16). Another 
difference was the orientation of the acceptor substrate. Compared to wild type Cp3GT, the 
orientation of the acceptor substrates was different with the mutant P145T enzyme (indicated by 
the red circle in Fig.2.14- 2.16). The acceptor substrate is rotated by 900. The most significant 
influence of the catalytic residue histidine on the active site is deprotonation of the –OH group of 
the acceptor substrate. The proximity of the catalytic residues His22, Ser20 and Asp122 might be 
the reason for differential orientation of the acceptor substrate at the active site. The orientation 
of the acceptor substrate at the active site might be the reason for altered substrate and 
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regiospecificity of wild type Cp3GT and mutant P145T as the orientation of the acceptor 
substrate affects the interaction of –OH groups with the catalytic residues and hence might 
influence the glucosylation reaction.  
3.5. Molecular docking with acceptor substrates and protein-ligand interaction 
 
 Recombinant wild type Cp3GTand mutant P145T were docked in silico with acceptor 
substrates quercetin, kaempferol, and naringenin (Fig.2.17-2.19). The catalytic dyad His-Asp is 
widely conserved among the flavonoid UGTs (Breton et al. 2012). The distance of these catalytic 
residues with the carbonyl and hydroxyl group of acceptor substrate is considered to be 
important for the acceptor substrate specificity as well as the enzyme catalyzed reaction (Offen et 
al. 2006). A distance within 5Å between the catalytic residue His22 and the -OH of the acceptor 
molecule, side chain of Asp122 and N€2 atom of His22 and side chain of Ser20 with the O-atom 
of 4-carbonyl group of the acceptor substrate indicates a likelihood of the sugar attaching 
reaction (Offen et al. 2006). Molecular docking of different acceptor substrates with the enzyme 
elucidates the residues within the binding site that are capable of forming hydrogen bond with –
OH groups of the acceptor substrates. Hydrogen bonds between the –OH group of the sugar 
acceptor and the different residues within the active site of the enzyme are critical for the 
glyucosylation reaction.  
Crystal structures of these related GTs have shown a common acceptor recognition 
pattern. A catalytic mechanism of the formation of 3-O-glucosylated product has been recently 
postulated (Hiromoto et al. 2015). Histidine17 in the UDP-glucose: anthocyanidin 3-O-
glucosyltransferase, UGT78K6 from Clitoria ternatea, acts as a Bronsted base that deprotonates 
the 3-OH group of the acceptor substrate (Hiromoto et al. 2015). Acidic residue Asp114 is 
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involved in charge stabilization. His-Asp catalytic activity is analogous to the Ser-His-Asp triad 
of serine hydrolases (reviewed in McIntosh and Owens 2016). After the deprotonation of the 
glucose accepting group of the acceptor molecule, the anomeric carbon, C1, of glucose 
undergoes nucleophilic attack by an oxyanion (Lairson et al. 2008). During the transition state, 
the negative charge of the leaving phosphate group of the donor may be stabilized by positively 
charged His at position 363 (Hiromoto et al. 2015). Similarly, it was suggested that Asp181 
determines the orientation of the acceptor at the acceptor binding site and plays an important role 
in the differentiation of the regioselective glucosylations (Hiromoto et al. 2015). 
The crystal structures of six GTs show that this catalytic dyad His17-Asp114 in 
UGT78K6 (Clitoria ternatea) is conserved as His22-Asp 121 in UGT71G1 (Shao et al. 2005), 
His20-Asp119 in VvGT1 (Offen et al. 2006), His21-Asp125 in UGT85H2 (Li et al. 2007), and 
His19-Asp 117 in AtUGT72B1 (Brazier-Hicks et al. 2007). In all of these GTs, histidine is 
located at a distance within 5Å from C1 of UDP-glucose and the acidic residue aspartic acid. We 
generated structural models and docked different acceptors with the wild type Cp3GT and 
mutant P145T and looked at the distances within each models to determine if models would 
predict the likelihood of the glucosylation reactions. These predictions were compared with the 
experimental results and models were validated.   
3.5.1. Docking with quercetin  
  
In the docking models, the 3-OH group of the acceptor substrate quercetin was positioned 
at a distance of 2.88 Å from the N€2 atom of the His22 catalytic residue in wild type Cp3GT 
whereas in mutant P145T it is located at a distance of 4.9 Å (Fig. 2.17). Serine 20 was located 
closer to the 4-carbonyl oxygen in Cp3GT (3.6 Å) compared to a distance of 5.6 Å in mutant 
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P145T. Asp 122 is located closer to the His22 (4.4 Å) in Cp3GT and 4.3 Å in mutant P145T. 
Asp 122 is reported to be involved in charge stabilization after the deprotonation of the OH 
group of the acceptor.  
Molecular docking with quercetin revealed many amino acid residues that could interact 
with the OH group of the acceptor. The closer proximity of catalytic residue His22 and Ser20 
might be the reason of a slightly higher glucosylation activity of wild type Cp3GT with quercetin 
compared to mutant P145T. In wild type Cp3GT, Pro145 is closer to the 3-OH group of the 
acceptor and might be involved in non-covalent interactions such as Van der Waals forces. 
A                                                                                                       
B 
 
Fig. 2. 17 Molecular docking of wild type Cp3GT and mutant P145T with quercetin. A) Cp-3-O-
GT and B) P145T with quercetin. The distance of residues predicted to be within the active site 
are measured in Å. 
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In mutant P145T, threonine145 does not seem to be involved in any type of interactions 
with quercetin in the models shown. This might be the reason for slight lower activity with 
mutant P145T. In wild type Cp3GT His154, Asp387, and His363 were found to be interacting 
with OH and the carbonyl group (Fig. 2.17, A). His154 is positioned at an H-bonding distance 
(4.7Å) from the 4’-OH group in the wild type Cp3GT model. The imidazole ring of His154 
forms H-bond with the 4-‘OH group in VvGT (Offen et al. 2006) which was observed in this 
model with Cp3GT. His363 was found to be present within the H-bonding distance from 7-OH 
group (4.2Å) as well as 5-OH group (4.03Å) in wild type Cp3GT model. His363 is involved in 
the stabilization of the charge of the leaving phosphate group of the sugar donor (Hiromoto et al. 
2015). Its proximity within the active site suggests it might have a role in enzyme catalyzed 
reaction.  
In the mutant P145T model docked with quercetin, His154 does not make any interaction 
with the acceptor unlike that seen in wild type Cp3GT model (Fig. 2.17). Other residues such as 
Asp387, Glu87, and Ser150 interact with the acceptor within H-bonding distance, but they do not 
make any contact within the 3-OH group of the acceptor. Ser20 forms an H-bond with carbonyl 
group of C-ring (2.09 Å), Glu87 H-bonds with 4’-OH (3.33 Å), Asp 387 is closer to 4-carbonyl 
of the C-ring (4.9 Å) and 5-OH (2.56), His363 closer to 7-OH group as in Cp3GT and Ser150 
closer to 4-carbonyl oxygen of C-ring (4.4 Å). In this model, different residues are interacting 
with the acceptor substrate, however, as the catalytic residues are positioned at a greater distance 
from the 3-OH group and the 4-carbonyl group compared to wild type Cp3GT, the model might 
be the predictive of the role of catalytic residues as well as role of His154 in orienting acceptor 
substrate within the active site.  
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3.5.2. Docking with naringenin  
 
 Docking with naringenin shows the residues located within the active site and the 
distance of the catalytic residues from the 7–OH group of the acceptor (Fig. 2.18). Mutant P145T 
is active with naringenin whereas there is no activity with wild type Cp3GT. In mutant P145T, 
the catalytic residue His22 is positioned at a distance of 4.67Å from the sugar accepting 7-OH 
group, whereas in Cp3GT the distance is 7.5Å. Ser20 is interacts with 4-carbonyl group of C-
ring at a closer distance (5.1 Å) compared to that with wild type Cp3GT (8.6 Å). However, the 
distance of Asp 122 is similar in both wild type and mutant. 
 
 
A. B. 
   
Fig. 2. 18 Molecular docking of wild type Cp3GT and mutant P145T with naringenin. A) Cp-3-
O-GT and B) P145T with naringenin. The distance of residues predicted to be within the active 
site are measured in Å. 
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The closer proximity of the catalytic residue His22 to the 7-OH group of naringenin in 
the P145T model could likely be the reason for the activity of mutant P145T with naringenin.  
The involvement of serine20 in forming an H-bond with the 4-carbonyl group of naringenin 
could be a reason for the activity with mutant P145T as the involvement of side chain of 
Serine18 in VvGT (position specific residue in Cp3GTis Serine20) in forming an H-bond with 
the 4-carbonyl group of the acceptor substrate is considered to be important in orienting substrate 
within the active site for glucosylation reaction (Offen et al. 2006). 
In mutant P145T, threonine145 may be involved in non-covalent interactions such as Van 
der Waals interaction with the 7-OH group as it is positioned closer (3.2 Å). Threonine in the 
mutant P145T model might be involved in a conformational change which might cause other 
residues to be involved in different interactions for enzyme activity such as in mutant P145T 
model, Asp387 is in closer proximity with 7-OH group (5.1 Å) and Asp387 is also positioned 
within H-bonding distance from the 5’-OH group (4.0 Å) and the 4-carbony group of C-ring (4.9 
Å) whereas in wild type Cp3GT, Asp387 is likely to interact only with the 4-carbonyl group of 
C-ring. In wild type Cp3GT, only His154 seemed to be interacting with the 5-OH group (2.8 Å) 
while other residues do not appear to be involved in any kind of interactions. 
This suggests that along with the closer proximity of the catalytic residues His22, Ser20, and 
Asp122, other residues such as Asp387, Thr145, and His363 might have a role in the activity of 
the mutant P145T with naringenin. Interestingly, Thr145 was found to be in closer proximity to 
the sugar accepting 7-OH group. The activity of mutant P145T with naringenin could be due to 
structural change due to a single point mutation of proline to threonine. When model with lowest 
DOPE score did not agree with experimental results, additional models were examined and these 
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models were the most energy favorable models that predicted the likelihood of reaction with 
mutant P145T enzyme.   
2.5.3. Docking with kaempferol 
 
The activity of mutant P145T with kaempferol is almost 2 fold greater than the wild type 
Cp3GT (Table 2.1 and Fig. 2.8). The distance of catalytic residue His22 from the 3-OH group of 
kaempferol for mutant P145T is 2.9 Å whereas in wild type Cp3GT, it is 4.6 Å (Fig. 2.19). 
Similarly, Ser 20 is located more closely (5.0 Å) in mutant P145T from the 4-carbonyl group of 
C-ring compared to wild type Cp3GT (5.9 Å). Asp122, involved in charge stabilization, is 
located at a similar distance from the catalytic residue His22 in both wild type and mutant 
P145T.  
 
A.       B. 
                          
 
 Fig. 2. 19 Molecular docking of wild type Cp3GT and mutant P145T with kaempferol.  A) 
Cp3GT and B) P145T with kaempferol. The distance of residues predicted to be within the active 
site are measured in Å. 
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 In the docking model, Thr145 in mutant P145T is closer to the 3-OH group (4.51 Å), 
whereas the corresponding residue in wild type Cp3GT, Pro145, is near to the 5-OH (4.4 Å) not 
the 3-OH. In mutant P145T, Ser150 is interacting with 4-carbonyl group of the C-ring (4.8 Å). In 
contrast, Ser150 is at a distance of 5.0 Å in wild type Cp3GT. His 154 is closer to the 7-OH 
group in mutant P145T (3.6 Å) whereas His 154 is interacting with the 4’-OH in wild type 
Cp3GT (3.9 Å). Asp387 is close to 5-OH group (4.6 Å) as well as 4-carbonyl group (4.0 Å) in 
mutant P145T, whereas in Cp3GT, Asp 387 is interacting with the 3-OH group (5.3 Å). These 
models predict structural change with this mutation that results in kaempferol docking 
differently.  
The closer proximity of the catalytic residues as well the interactions of other residues 
such as Thr145, Asp387, His154, and Ser150 with the acceptor substrate suggests the likelihood 
of increased catalytic activity with mutant P145T.  The experimental results with kaempferol are 
in agreement with these computational models that mutant P145T had increased activity with 
kaempferol. The energy minimization for mutant P145T for this model is -7.7kcal/mol whereas 
for the wild type it is -8.1kcal/mol. His145 and Serine150 in mutant P145T interact with the 4-
carbonyl group and the 3-OH group of the acceptor molecule respectively to form an H-bond. 
The involvement of serine and histidine in forming an H-bond, although at a different location 
but in closer proximity to the acceptor substrate binding site, might be a reason for the increased 
activity as the roles of these residues in forming an H-bond for acceptor substrate specificity 
have been previously discussed [27]. Thr145 is interacting with the sugar accepting 3-OH group 
at an H-bonding distance whereas the corresponding residue in wild type Cp3GT is interacting 
with the OH group that is not involved in glucosylation reaction. This suggests Thr145 at the 
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closer proximity of the acceptor substrate might be responsible for structural change of the 
protein that can impact functional differences.  
3.6. Insertion of thrombin site and heterologous expression 
 
Primers for insertion of a thrombin cleavage site were designed (Table B.1). Site-directed 
mutagenesis PCR was done to clone a thrombin cleavage site into recombinant wild type Cp3GT 
and mutant P45T between the enzyme and C-myc/6x-His tags. This was done in preparation to 
crystallize proteins as well as to test the effect of tags on recombinant enzyme activity.  
Site-directed mutagenesis PCR product of both wild type and mutant P145T was first 
transformed in E.coli (Fig. 2.20) and the positive transformants were re-streaked on LB agar 
plates and confirmed by colony PCR (Fig. 2.21). The insertion of thrombin site in-frame was 
confirmed by sequencing (Fig. 2.22- 2.23). Plasmid was extracted and linearized using SacI (Fig. 
2.24) and work is in progress for its transformation into Pichia pastoris for recombinant 
expression.  
                                          
 
                                  
                             
 
Fig. 2. 20 Colony PCR of positive transformants having thrombin site. Agarose gel 
electrophoresis of the product of Colony PCR of wild type Cp3GT and mutant P145T plasmid 
with thrombin site, transformed into competent E.coli. PCR was performed with AOX primers. 
L- 1kb DNA ladder, A)Lane 1 to 7- mutant P145T, and B) Lane 8-14 wild type Cp3GT having 
thrombin site. 
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 Fig. 2. 21 Colony PCR of positive transformants of E.coli. having thrombin cleavage site. 
Agarose gel electrophoresis of the product of the Colony PCR of wild type Cp3GT and mutant 
P145T plasmid positive transformants with thrombin site, transformed into competent E.coli. 
PCR was performed with AOX primers. L- 1kb DNA ladder, A)Lane 1 to 7- mutant P145T, and 
B) Lane 8-14 wild type Cp3GT having thrombin site. 
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Fig. 2. 22 Sequencing of mutant P145T with thrombin site. Sequencing results of insertion of 
thrombin cleavage site (leu-val-pro-arg-gly-ser). P145T-pPICZA represents the mutant P145T 
sequence in pPICZA vector containing gene of interest as well as C-myc and His tags. P145T-
TCS represents the consensus sequence obtained with 5’ and 3’ primers as well as internal 
primers of the mutant P145T with thrombin cleavage site inserted. Thrombin cleavage site and 
the tags are highlighted in red and black respectively.  
 
 
 
 
 
 
Thrombin cleavage site 
 
C-myc tags 
6x-His tags 
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Fig. 2. 23 Sequencing of wild type Cp3GT with thrombin cleavage site. Sequencing results of 
insertion of thrombin cleavage site (leu-val-pro-arg-gly-ser). WT-pPICZA represents the wild 
type Cp3GT sequence in pPICZA vector containing gene of interest as well as C-myc and His 
tags. WT-TCS represents the consensus sequence obtained with 5’ and 3’ primers as well as 
internal primers of wild type Cp3GT with thrombin cleavage site inserted. Thrombin cleavage 
site and the tags are highlighted in red and black respectively.  
 
 
 
 
 
 
 
 
 
 Fig. 2. 24 Digestion of Cp3GT plasmid in pPICZA and P145T plasmid in pPICZA having 
thrombin site with SacI. Agarose gel electrophoresis of the wild type Cp3GT and mutant P145T 
plasmid with thrombin site before and after digestion with SacI. L- 1kb DNA ladder, lane 1- non-
linear mutant P145T plasmid, lane 2- linearized mutant P145T, lane 3- non-linear wild type 
Cp3GT, lane 4- linearized wild type Cp3GT.  
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4. Conclusions   
 
   Substitution of proline to threonine brought structural change in the protein. Mutant 
P145T showed altered substrate as well as regiospecificity. Initial screening of mutant P145T 
with different aglycones showed increased activity with kaempferol and ability to glucosylate 
flavanones and flavones that do not contain 3-OH group for glucosylation. The activity with 
different acceptors quercetin, kaempferol, and naringenin were verified by identifying the 
products of the reaction. HPLC analysis for product identification showed that the mutant P145T 
glucosylates naringenin at the 7-OH position forming naringenin-7-O-glucoside (prunin); 
flavonols are glucosylated at 3-OH position. After confirming activity with hesperetin, and 
scutallerein detailed kinetic studies with quercetin, kaempferol, naringenin, hesperetin, and 
scutallerein should be done as kinetic studies elucidates the biochemical function of the enzyme 
with details about the catalytic efficiency of the enzyme, turnover number, and the affinity of the 
enzyme with the substrates (apparent Km).  
Homology modeling and molecular docking was done to generate computational models 
and models were validated by experimental results. The catalytic residues His22, Ser20, and 
Asp122 were found to interact with acceptor substrate at the active site. Homology modeling 
with other acceptor substrates such as hesperetin and scutallerein as well as with the donor 
substrate UDP-glucose could further elucidate the substrate recognition pattern. 
 Thrombin cleavage site was inserted into the wild type Cp3GT and mutant P145T 
between the enzyme and the C-myc tags in order to be able to cleave off tags. In addition to 
testing biochemical activity with and without tags, the ability to cleave the tags makes it possible 
to try to crystallize protein. Crystal structures should be attempted for wild type Cp3GT and 
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mutant P145T in the presence of acceptor substrate with high recombinant enzyme activity. Out 
of six glucosyltransferases whose crystal structures have been published, VvGT and UGT78K6 
glucosylates both anthocyanidins and flavonols whereas our enzyme Cp3GT is strictly a flavonol 
specific. Crystalizing wild type Cp3GT and mutant P145T that had altered substrate and 
regiospecificity could possibly explain the substrate recognition patterns of this flavonol specific 
GT. 
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CHAPTER 3 
 SUMMARY AND DIRECTIONS FOR FUTURE RESEARCH 
 
 In this research, site-directed mutagenesis, homology modeling and biochemical assay of 
recombinant wild type Cp3GT and mutant P145T enzyme with different flavonoid substrates 
was performed for the structure-function study of flavonol specific 3-O-glucosyltransferase from 
Citrus paradisi (Cp3GT). UPD-glucose; flavonoid 3-O-glycosyltransferase from Vitis vinifera 
(VvGT) glucosylates flavonols as well as anthocyanins at the 3-OH and the 7-OH positions 
respectively (Offen et al. 2006). VvGT and Cp3GT share 56% sequence identity and 87% 
homology. Cp3GT was modeled with VvGT to design a Cp3GT-P145T mutant by substituting 
proline145 of Cp3GT with threonine to test the hypothesis that mutation of proline in Cp3GT by 
threonine can alter substrate and regiospecificity of Cp3GT. Homology models showed that 
threonine 141 was closer to the substrate binding pocket of VvGT and the corresponding residue 
in Cp3GT was proline 145. Therefore, the models suggest a structural change. As the cyclic 
structure of proline's side chain provides proline an exceptional conformational rigidity that 
forces a bend in the structure of the protein, it was hypothesized that replacing the amino acid 
that imparts structural rigidity by a residue that allow free rotation resulting in different 
orientation or may expose protein to different interactions resulting in a change in the structure 
and hence the catalytic properties of enzyme.  
The recombinant enzyme activity of the wild type Cp3GT and mutant P145T enzyme 
was assayed with 15 different flavonoid substrates. HPLC was performed to verify the activity 
assay with quercetin, kaempferol, and naringenin. Computational models were generated and 
molecular docking was performed to predict the location of amino acid residues that are critical 
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for enzyme activity and function. The computational models were validated by in vitro results. In 
other work, a thrombin cleavage site was inserted into the wild type Cp3GT and mutant P145T 
in between the enzyme and the C-myc tags in order to be able to cleave off tags.  
The mutant P145T enzyme possessed altered substrate and regiospecificity, glucosylating 
flavones and flavanones along with flavonols. Acceptor substrate specificity was performed by 
the activity screening assay and activity was confirmed for quercetin, kaempferol and naringenin 
by product identification using HPLC, also by time course study for quercetin and kaempferol. 
Product identification with other potential acceptor substrates such as scutallerein and hesperetin 
should be performed as the mutant P145T showed activity with these acceptors in the screening 
assay. Because the screening assay is a highly sensitive assay that uses radioactive UDP-glucose 
and can give false positive results, the acceptor substrate specificity should be further confirmed 
by performing an assay with unlimiting non-radioactive UDP-glucose. In order to explain the 
mechanism of enzyme catalysis and function, the mutant P145T could further be biochemically 
characterized by detailed kinetic study of activity with quercetin, kaempferol, naringenin, 
hesperetin and scutallerein.  
Models of wild type Cp3GT and mutant P145T were generated and molecular docking 
was used to generate computational models by docking wild type Cp3GT and mutant P145T 
with quercetin, kaempferol, and naringenin. This provided insight into the key residues that 
might have a role in the altered substrate and regiospecificity observed. It was found that the 
catalytic triad His-Asp-Ser was present at the active site of the enzyme within a distance of 5Å 
from different interacting groups of the acceptor substrate. The proximity of these catalytic 
residues with the acceptor substrate was used to compare to the in vitro results. The 
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computational models were further validated using experimental results supporting the role of 
different amino acids in the enzyme activity. Homology modeling and molecular docking further 
provided insight into the possible orientation of the substrate in active site of the enzyme and the 
change in the confirmation of enzyme due to the point mutation.  
The most significant change in mutant P145T compared to wild type Cp3GT was 
observed at the region between the N and C domain that forms a cleft for binding donor and 
acceptor substrate. The models generated suggested the likelihood of the reaction due to the 
increased proximity of the catalytic residues with the –OH group of the acceptor. Threonine145 
was found in close proximity to the sugar accepting group of kaempferol and naringenin in 
models with mutant P145T. This residue might be involved in non-covalent interactions such as 
Van der Waals forces causing a change in the structure of the protein within the active site. 
Similarly, molecular docking had revealed the roles of other amino acid residues that were 
present within the active site. Asp387, His154, Ser150, and Glu87 were found to interact with 
the acceptor substrate within the active site suggesting residues other than the catalytic triad 
might have a role in acceptor substrate recognition.  
After confirming the enzyme activity with other substrates such as hesperetin and 
scutallerein, molecular docking analysis should be performed with these substrates as the mutant 
P145T had activity with these substrates in screening assay. In the future, wild type and mutant 
P145T could be docked with the sugar donor that could explain the roles of amino acid in the 
donor substrate recognition pattern. Docking with donor and acceptor substrate on the active site 
could also explain the roles of the amino acids in the enzyme activity and function as well the 
interaction and the orientation of the substrate at the active site. As active site is formed in a 
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narrow cleft between N-terminal and C-terminal domain, docking with both acceptor and donor 
might explain the mechanism of enzymatic reaction further as was done for VvGT (Offen et al. 
2006).  
The recombinant wild type Cp3GT expressed in E.coli was investigated for the effects of 
N-terminal vector-encoded thioredoxin and 6x His tags by comparing the thrombin-treated and 
untreated recombinant enzyme (Owens and McIntosh 2009). No effect on the enzyme activity 
was observed whether the tags were present or absent. However, changing the expression system 
from bacteria to yeast brought a change in the activity of recombinant enzyme with increased 
stability at higher pH values although the substrate preference for flavonols, effect of metals 
ions, Ki value for inhibitor UDP, temperature optimum and temperature stability were similar 
(Devaiah et al. 2016). This could be due to different chemistry and nature of C-myc/6x-His tags 
in the yeast expression system as well as position of C-myc tags in the yeast expression system 
whereas thioredoxin tags were at the N-terminus. In this research, a thrombin site has been 
inserted into both wild type Cp3GT and mutant P145T just before the C-myc tags in C-terminus. 
Biochemical characterization of wild type and mutant P145T enzyme in absence of tags should 
further provide insight into the effects of tags in the recombinant enzyme activity.  
In addition to testing biochemical activity with and without tags, the ability to cleave the 
tags makes it possible to try to crystallize protein. Crystal structures should be attempted for 
native WT protein and protein crystallized in the presence of acceptor substrate with high 
recombinant enzyme activity. Out of six glucosyltransferases whose crystal structures have been 
published, VvGT and UGT78K6 glucosylates both anthocyanidins and flavonols whereas our 
enzyme Cp3GT is strictly a flavonol specific. Crystalizing wild type Cp3GT and mutant P145T 
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that had altered substrate and regiospecificity could possibly explain the substrate recognition 
patterns of this flavonol specific GT. Out of six different crystal structures of family 1 GTs, 
VvGT and UGT78K6 have specificity with anthocyanidins and flavonols whereas Cp3GT 
glucosylates flavonols only. VvGT and UGT78K6 have similar acceptor recognition pattern. 
Crystalizing Cp3GT could possibly explain the substrate specificity patterns of this flavonol 
specific GT. Mutant P145T had altered substrate and regiospecificity and models generated 
predicted the likelihood of reaction. Crystalizing P145T with kaempferol and naringenin could 
possibly help in the comparison of the pattern of acceptor substrate specificity and roles of 
different residues in altering the strict specificity of wild type Cp3GT. This could further explain 
the roles of threonine in the altered specificity of the enzyme. Along with this research, earlier 
work on some on some of the mutations in our lab should be considered for crystallization. For 
example a mutant S20L (serine mutated to leucine) and P297F (proline mutated to 
phenylalanine) completely abolished the enzyme activity (Adepoju 2014). Similarly, another 
double mutant S20G+T21S altered the substrate specificity with mutant glucosylating flavanones 
as well as flavonols (Sathanantham 2015). This could possibly explain the roles of different 
amino acids in the enzyme activity and better aid in the custom designing of enzyme for 
biotechnological and pharmaceutical applications to synthesize compounds of enhanced 
nutritional and health benefits.   
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 APPENDICES 
APPENDIX A: RECIPES 
 
Acceptor substrates (aglycones) for enzyme assay 50nmol/5µL (1 mL) 
Quercetin   
3.4 mg Quercetin 
Dissolve in 1mL of ethylene glycol monomethylether (EGME) 
Vortex to dissolve completely 
Store at -20ºC 
 
Kaempferol   
 
2.86 mg of Kaempferol 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Fisetin   
 
2.86 mg of Fisetin 
Dissolve in 1mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Gossypetin   
 
3.18 mg of Gossypetin 
Dissolve in 1mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
4’methoxyflavonol   
 
2.68 mg of 4’methoxyflavonol 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
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Dihydroquercetin   
 
3.04 mg of Dihydroquercetin 
Dissolve in 1mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Naringenin   
 
2.72 mg of Naringenin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Hesperetin   
 
3.02 mg of Hesperetin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Eriodyctiol   
 
2.88 mg of Eriodyctiol 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Isosakuranetin   
 
2.86 mg of Isosakuranetin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Luteolin   
 
2.86 mg of Luteolin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
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Diosmetin   
 
3.0 mg of Diosmetin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Cyanidin chloride 
 
2.87 mg of cyanidin chloride 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Apigenin   
 
2.7 mg of Apigenin 
Dissolve in 1mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
Scutallerein   
 
2.86 mg of Scutallerein 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
 
4’-acetoxy-7-hydroxy-6-methoxy isoflavone   
 
3.26 mg of Diosmetin 
Dissolve in 1 mL of EGME 
Vortex to dissolve completely 
Store at -20°C 
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Sugar donor (UDP- glucose) 
 
Non-radioactive for HPLC 
 
100nmol UDP-α-D-glucose Disodium Salt (non-radioactive)/10µL, 1mL  
6.1 mg of UDP-α-D-glucose  
Dissolve in 1000 µL of sterile dH2O 
Vortex before use and store at -20 oC 
 
Radioactive UDP-glucose, for activity screening assay 
 
UDP-14
C
-glucose- 22,000 cpm/10 µL, 400µL 
20µL of UDP-14C glucose (Specific activity=50 µCi/2.5 ml) 
380µL of dH2O 
Vortex well and verify cpm by adding 2µl of the mix to 2 ml scintillation cocktail 
Store at -20 °C 
 
 
Kinetic assays and biochemical characterization 
 
UDP-14
C
-glucose (radioactive) – 45,000cpm, 100nmol/10µL, 400µL 
6.78mg of UDP-glucose dissolve in 1mL of dH2O = 100nmol/9µL (Stock solution) 
40µL of UDP-14C glucose (Specific activity=50 µCi/2.5 ml)  
360µL of non-radioactive UDP-glucose (100nmols/9 µL) 
Vortex well and verify cpm by adding 2µL of the mix to 2 ml scintillation cocktail 
Store at -20 °C 
 
Media and Buffers 
 
Protein expression 
Low salt Luria broth (LB) liquid media (200 ml)  
1 g yeast extract (0.5%)  
2 g tryptone (1%)  
2 g sodium chloride (1%) 
 
Dissolve ingredients in 180 ml dH2O 
Adjust pH to 7.5 with 1M NaOH 
Make up the volume to 200ml using miliQ dH2O 
Sterilize by autoclaving for 20 minutes                                                                                                                                                                                                                                                
After the solution gets cooled, add 50 µL of filter sterilized zeocin from (100 mg/mL stock) to a 
final concentration of 25 µg/ml media 
Store at 4°C 
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Low salt LB-Agar plates (200 mL)  
1 g yeast extract (0.5%)  
2 g tryptone (1%)  
2 g sodium chloride (1%) 
 
Dissolve ingredients in 150 mL dH2O 
Adjust to pH=7.5 with 1M NaOH 
Add 3 g agar (1.5%) 
Make up volume to 200 mL with dH2O 
Autoclave for 20 minutes 
Allow to cool to ~55°C and add 50 µL of filter sterilized zeocin from (100 mg/mL stock)  
Pour 25ml of media into plates and allow to solidify 
Store at 4°C in the dark 
YPD (200mL) 
2 g yeast extract (1%)  
4 g peptone (2%) 
Dissolve ingredients in 180 mL dH2O (Adjust final pH=6.5) 
Autoclave for 20 minutes 
Cool to room temperature 
Add 20mL of autoclaved 20% dextrose (final concentration of 2%) 
Add 200 µL of filter sterilized zeocin from (100 mg/mL) stock. 
Store at 4°C 
 
YPD-Agar Plate (200mL)  
2 g yeast extract (1%)  
4 g peptone (2%) 
Dissolve ingredients in 180 mL dH2O (Final pH=6.5)  
Add 4 g agar (2%) 
Autoclave for 20 minutes 
Cool to about 55°C and add 20 mL of autoclaved 20% dextrose   
Add 200 µL of filter sterilized zeocin from (100 mg/mL) stock 
Mix well and pour 25ml in each plate and allow it to solidify 
Store plates at 4°C in dark 
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YPDS  
2 g yeast extract (1%) 
4 g peptone (2%) 
36.44 g sorbitol 
Dissolve in 180 mL dH2O (Final pH=6.5) 
Autoclave for 20 minutes 
Allow to cool to room temperature 
Add 20 mL of autoclaved 20% dextrose  
Add 200 µL zeocin from (100 mg/mL) stock 
YPDS-Agar plates (200 mL)  
2 g yeast extract (1%)  
4 g peptone (2%) 
36.44 g sorbitol 
Dissolve in 180 mL dH2O (Final pH=6.5) 
Add 4 g agar (2%) 
Autoclave for 20 minutes 
Allow to cool and add 20 mL of autoclaved 20% dextrose  
Add 200 µL zeocin from (100 mg/mL) stock 
Mix well and pour 25 mL into each plate and allow to solidify 
Pour media into plates and allow solidify 
Store plates at 4°C in dark 
 
Zeocin (100mg/mL) stock solution (1mL) 
100mg zeocin 
Dissolve in 1mL dH2O 
Filter sterilize 
Store at -20°C in dark 
10X Dextrose (20% Dextrose) (100 mL) 
20 g dextrose (α-D-glucose)  
Dissolve in 100 mL dH2O 
Autoclave for 20min and store at room temperature  
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BMGY (1L) 
10 g yeast extract 
20 g peptone 
Dissolve in 700 mL sterile dH2O 
Autoclave for 20 min  
Allow to cool at room temperature 
 
Add:  
  100 mL autoclaved 1M potassium phosphate buffer (pH=6.0) 
  100 mL filter sterilized 1M 10X YNB 
  100 mL filter sterilized 10X Glycerol  
  2 mL filter sterilized 500X Biotin 
  Store at 4°C  
 
BMMY (1L) 
10 g yeast extract 
20 g peptone 
Dissolve in 700 mL dH2O 
Autoclave for 20 min   
Allow to cool at room temperature 
 
Add:  
  100 mL autoclaved 1M potassium phosphate buffer (pH=6.0) 
  100 mL filter sterilized 1M 10X YNB 
  100 mL filter sterilized 10X Methanol (add methanol just before use) 
  2mL 500X Biotin 
  Store at 4°C 
 
10X GY (10% glycerol) (1000ml) 
 
100 mL of 100Xglycerol  
Mix 900 mL dH2O 
Autoclave for 20 min 
Store at 4oC 
 
10X YNB (500 mL) 
 
17 g yeast nitrogen base 
50 g ammonium sulfate 
Dissolve in 500 mL dH2O  
Heat slightly to dissolve the ingredients completely 
Filter sterilize the solution and store at 4°C 
 
130 
  
 
500X Biotin (0.02% Biotin) 100ml 
 
20 mg biotin  
Dissolve in100 mL dH2O  
Filter sterilize the solution 
Store at 4°C  
 
 
10X M (5% Methanol) (500 mL) 
 
25 mL methanol 
Add 475 mL of dH2O 
Filter sterilize  
Store at 4°C  
 
1M potassium phosphate buffer, pH=6.0 
 
87.09g of dibasic potassium phosphate (K2HPO4)  
Dissolved in 500mL of dH2O 
 
136.09g of monobasic potassium phosphate (KH2PO4)  
Dissolved in 1000mL of dH2O 
 
Mix 132mL of 1M dibasic potassium phosphate (K2HPO4) + 868 mL of 1M monobasic 
potassium phosphate (KH2PO4)  
Make up pH of 6.0 
Autoclave for 20 minutes at liquid cycle and store at 4°C 
 
Agarose gel electrophoresis 
0.8% Agarose Gel (50mL) 
0.4 g Agarose 
Dissolve ingredient in 50 mL 1X TAE buffer 
Microwave for 60 to 70 seconds until agarose dissolves 
Add dH2O to make up volume of 50mL 
Allow to cool and add 2.5µL of a 10mg/mL ethidium bromide 
Mix well and pour 40ml into gel casting tray 
50X TAE buffer (1L) 
242 g Tris base 
57.1 mL glacial acetic acid 
Add 100 mL of 0.5M EDTA (pH=8.0) 
Dissolve the ingredients in ~700 mL dH2O 
Make up volume to 1L with dH2O and store at room temperature 
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1X TAE (1L) 
Take 20mL of 50X TAE stock and make up volume to 1L adding 980mL dH2O 
 
SDS-PAGE electrophoresis 
10X- Running buffer (1L) 
30.28g Tris base 
144.14g glycine 
10g SDS 
Dissolve in 1000ml DH2O 
Store at room temperature 
 
1X- Running buffer 
100mL of 10X stock 
Add 900mL of DH2O 
 
4X-Separating buffer (1.5M Tris, pH 8.8) 100mL 
18.2g Tris base 
Dissolve in 80ml H2O 
Adjust pH to 8.8 using 6M HCL 
make up volume to 100ml 
Filter sterilize the solution 
Store at 4oC 
4X-Stacking buffer (1M Tris, pH 6.8) 100mL 
12.1g Tris base 
Dissolve in 80mL dH2O 
Adjust pH to 6.8 with 6M HCl 
Make up volume to 100 mL with dH2O 
filter sterilize and store at 4oC 
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4X SDS-PAGE Sample Buffer (10mL) 
2.4mL of 1M Tris, pH 6.8  
0.8g SDS (sodium lauryl sulfate)  
4mL 100% glycerol 
4mg bromophenol blue 
3.1mL dH2O 
Store at room temperature 
Add 50 µL of βME per mL of 4X sample buffer immediately before use. 
 
10% SDS-PAGE Gel 
10% SDS (100 mL) 
10 g SDS 
Dissolve in 100 mL dH2O 
Store at room temperature 
 
10% APS (Ammonium persulfate) 
0.1g Ammonium persulfate 
Dissolve in 1mL dH2O (use fresh each time) 
 
Separating gel 
                             1 gel      2 gel 
H2O………………………………… 2.3ml     4.8ml 
40% Acrylamide…………….............1.3ml     2.5ml 
1.5M Tris (pH 8.8)………………… 1.3ml     2.5ml 
10% SDS…………………………… 50ul     100ul 
10% APS…………………………….50ul     100ul 
TEMED………………………...........2ul     4ul 
 
Stacking gel 
                                                              1 gel      2 gel 
 H2O………………………………….730ul      1.5ml 
40% Acrylamide ……………………..130ul      260ul 
1 M Tris (pH 6.8)……………………..130ul     250ul 
10% SDS……………………………...10ul      20ul 
10% APS…………………..………….10ul      20ul 
TEMED………………………..............1ul      2ul 
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Western blot 
10X Transfer buffer (1L) 
30.28g Tris base 
144.14g glycine 
Dissolve ingredients in 1000 mL dH2O 
Store at 4oC 
1X Transfer buffer (1L) 
100 mL of 10X stock 
Add 700 mL of dH2O 
Add 200 mL of methanol 
Mix and store at 4°C 
Blocking solution (50 ml) 
2.5 g non-fat milk powder 
Dissolve in 50 ml of 1X TBS and add 50 µL of 20% sodium azide 
 
20% sodium azide (1 ml) 
20 mg sodium azide 
Dissolve in 1 ml dH2O 
Store at 4 °C 
5X TBS buffer (1L) 
40g NaCl 
1g KCl 
15g Tris base 
Dissolve ingredients in 900mL dH2O 
Adjust to pH=7.4 with 6N HCl 
Make up to a final volume of 1L with dH2O 
Store at room temperature 
Primary Antibody (1:2500 dilution) 
6 µL of anti-C-myc monoclonal antibody from mouse 
Dissolve in 15 ml of 1X TBS 
Secondary Antibody (1:10,000 dilution) 
1.5 µL of anti-mouse IgG from goat 
Dissolve in 15 ml of 1X TBS 
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Alkaline phosphate (AP) buffer (pH 9.5) (500 ml) 
2.925 g NaCl 
507.5 mg MgCl2.6H2O 
50 ml of 1M CHES buffer (41.44g CHES dissolve in 200mL dH2O to make 200mL of 1M CHES) 
Dissolve ingredients in 475 ml dH2O 
Adjust pH to 9.5 
Make up the volume to 500ml using dH2O 
Store at room temperature 
 
Nitro blue tetrazolium (NBT) solution (1mL) 
83mg NBT dissolved in 700uL of N, N-dimethyl formamide and 300uL of dH2O 
Store at -20oC  
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) solution (1mL) 
 
42mg BCIP dissolve in 1mL of N, N-dimethylformamide 
Store at 20oC  
 
0.5 M EDTA (pH 8.0) (500 ml) 
73.06 g of EDTA  
Dissolve in 450 ml dH2O 
Adjust the pH to 8.0 
Make up the volume using dH2O  
Store at room temperature 
Protein extraction and purification 
Breaking buffer, pH 7.5 (500ml) 
50mM Sodium phosphate buffer (pH 7.5) 
1mM PMSF (Phenyl methyl sulfonyl fluoride)  
1mM EDTA 
5% glycerol 
5mM βME 
(PMSF and βME should be added before use) 
0.65 g monobasic Sodium phosphate  
5.5 g dibasic Sodium phosphate 
145mg EDTA 
Dissolve in 400ml DH2O 
Adjust pH to 7.5 
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Add 50mL of 50% glycerol 
Make up volume to 500mL 
Store at 4°C 
-Add 5ul of 200mM PMSF per ml of breaking buffer 
-Add 0.35µL of βME per mL of breaking buffer 
 
200mM PMSF (1mL)  
35mg of PMSF dissolved in 1mL methanol 
Store at -20°C 
  
50% glycerol (500ml)  
250mL of 100% 
Make up volume to 500mL adding dH2O 
Mix well and store at 4oC 
 
Equilibration/Wash buffer (pH=7.5) (500mL) 
50mM Sodium phosphate buffer (pH 7.5) 
300mM NaCl 
5mM βME 
0.65 g monobasic sodium phosphate 
5.5 g dibasic sodium phosphate 
8.75 g sodium chloride 
Dissolve in 450mL dH2O  
Adjust pH to 7.5 
Make up volume to 500mL with dH2O 
Store at 4°C 
Add 0.35µL of βME per mL of elution buffer prior to use 
 
Elution buffer, pH 7.5 (500 ml) 
50mM Sodium phosphate buffer (pH 7.5) 
300mM NaCl 
5mM βME 
150mM Imidazole 
0.65 g monobasic sodium phosphate 
5.5 g dibasic sodium phosphate 
8.75 g sodium chloride 
5.1 g imidazole 
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Dissolve in 450ml dH2O and adjust pH to 7.5 
Make up the volume using dH2O and store at 4 °C 
Add 0.35 µL of βME per mL of elution buffer prior to use 
 
 Assay/ Final buffer, pH 7.5 (500 ml)  
 
50mM Sodium phosphate buffer (pH 7.5) 
14mM βME 
0.65 g monobasic sodium phosphate 
5.5 g dibasic sodium phosphate 
Dissolve in 450ml dH2O and adjust pH to 7.5 
Make up the volume using dH2O and store at 4 °C 
Add 1µL of βME per mL of assay buffer prior to use 
 
 
IMAC column regeneration and storing 
20mM MES-KOH, pH 5.0 with 0.3M NaCl  
 
0.39 g MES 
1.75 g NaCl 
Dissolve in 100 ml dH2O 
Adjust pH to 5.0 using 1 M KOH 
Store at 4 °C 
 
IMAC Column storing solution (100 ml) 
20% ethanol containing 0.1% sodium azide 
 
20ml of 100X ethanol 
Make volume to 100ml using dH2O 
Add 100mg of sodium azide 
Mix well and Store at 4 °C 
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APPENDIX B: METHODS 
SDS-PAGE 
 
          Two 10% SDS-PAGE gels were prepared as described in Appendix A. Samples for SDS-
PAGE were made by mixing 5µL of SDS-PAGE sample buffer (Appendix) with 10-15µL of 
protein samples. The mixture was boiled for 5 minutes to denature the proteins. The SDS-PAGE 
tank was filled with 1X Tris-glycine electrophoresis running buffer (Appendix). A 5µL volume 
of pre-stained low molecular weight marker (Bio-rad) was loaded in the first well followed by 
protein samples. The samples were electrophoresed for 90 minutes at 100V. One gel was stained 
with Coomassie blue overnight keeping on a shaker and destained using destaining solution. 
Western blotting 
 
One of the two SDS-PAGE gels were used for western blot analysis to detect the 
proteins. A black and white transfer cassette was taken with black surface down. A white porous 
pad was placed over the cassette and then a filter paper above it followed by gel and then 
nitrocellulose membrane and then again white porous pad. In a Western blot tank, 1X ice cold 
transfer buffer was poured and the cassette was placed in the center of the tank. Electrophoresis 
was performed for 90 minutes at 100V. The nitrocellulose membrane was carefully removed and 
emerged in blocking solution for 2 hours at room temperature (or at 4oC overnight). The 
membrane was then washed for five minutes thrice with 15 mL of 1x TBS buffer containing 
15µL of 20% sodium azide. The primary antibody (Anti-C-myc monoclonal antibody from 
mouse, Sigma Aldrich) was diluted 1:2500 in 15mL of TBS buffer with 15mL of 20% Sodium 
azide. The membrane was immersed in primary antibody for 2 hours in a shaker and then washed 
again three times with TBS buffer. The membrane was then immersed in secondary antibody 
(Ant-mouse Immunoglobin G-alkaline phosphatase conjugate from goat, Novagen) for 2 hours at 
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room temperature. Again the membrane was washed with TBS three time for five minutes each. 
The membrane was immersed in 15mL of alkaline phosphate buffer (AP buffer, pH 9.0) for five 
minutes for buffer exchange. In another dish, 15mL of AP buffer was taken and 60µL of BCIP 
and 60µL of NBT was added and mixed well and the membrane was immersed in this solution 
until the protein band appeared. The membrane was then transferred to a separate dish containing 
a mixture of 15 ml TBS and 60 µL of 5M EDTA in order to stop the reaction. 
Insertion of thrombin cleavage site 
 
Primer design 
 
 Thrombin recognizes the consensus sequence leucine-valine-proline-arginine-glycine-
serine, cleaving the peptide bond between arginine and glycine. Primers specific for thrombin 
site were designed (Table B.1) using Quickchange Primer Design web tool from Agilent 
Technologies. 
(http://www.genomics.agilent.com/primerDesignProgram.jsp?&_requestid=994370). Site-
directed mutagenesis PCR was done to insert thrombin site in between the wild type cp3GT and 
mutant P145T enzyme and the C-myc tags.  
 
 Table B. 1 Primers for insertion of the thrombin site. Forward and reverse primers used for 
insertion of thrombin site between the enzyme and C-myc tags. 
Primer 
name 
Primer sequence Length Tm (
oC) 
 
CSP212-
1527R 
 
5'-GAGATGAGTTTTTGTTCGGAACCGCGTGGCACCAGGGGCCCAAGCTGGCGG-3' 
 
51 
 
81.62 
 
CSP211-
1527F 
 
5'-CCGCCAGCTTGGGCCCCTGGTGCCACGCGGTTCCGAACAAAAACTCATCTC-3' 
 
51 
 
81.62 
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Site-directed mutagenesis 
 
 Site-directed mutagenesis PCR was performed to insert thrombin site in between the wild 
type Cp3GT and mutant P145T enzyme and the C-myc tags using QuikChangeR Lightning Site- 
Directed Mutagenesis Kit from Agilent Technologies. The reaction mixture contained: 
P145T-thrombin cleavage site 
5µL of 10X reaction buffer  
1.25µL of 125ng/µL Primer (forward)  
1.25µL of 125ng/µL Primer (reverse) 
1µL of dNTP mix 
1.5µL of Quick solution reagent:  
1 µL of Quick change DNA polymerase enzyme 
39µL of P145T DNA template (45ng)  
Cp3GT-thrombin cleavage site 
5µL of 10X reaction buffer  
1.25µL of 125ng/µL Primer (forward)  
1.25µL of 125ng/µL Primer (reverse)  
1µL of dNTP mix 
1.5µL of Quick solution reagent:  
1 µL of Quick change DNA polymerase enzyme 
39µL of Cp3GT DNA template (35ng)  
 PCR was run using the following conditions as mentioned on the QuikChangeR Lightning 
Site- Directed Mutagenesis Protocol from Agilent Technologies. 
  Table B. 2 PCR conditions for insertion of thrombin site using site directed mutagenesis. 
Step Temperature (
o
C) Time(s) Cycles 
Initiation 95 30 1 
Denaturation 95 30 16 
Annealing 55 60 
Elongation 68 600 
Extension 68 600 1 
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The PCR product was run on 0.8% agarose gel to confirm the band of appropriate size 
(Supplementary Fig. C.2). 
DpnI digestion of parental DNA of the site-direct mutagenesis PCR product 
 
  The site directed mutagenesis PCR product of wild type Cp3GT and mutant P145T 
containing thrombin cleavage site in between the enzyme and the C-myc tags was treated with 
the restriction enzyme DpnI (Agilent Technologies) to digest the parental template DNA. 1µL of 
DpnI enzyme (10U/µL) was added to each of the 40µL of site-directed mutagenesis PCR 
products and mixed properly by pipetting up and down several times. Then the tubes were 
incubated at 37oC water bath for 1 hour. The digested product was run on 0.8% agarose gel 
(Supplementary Fig. C.3) to confirm the presence of intact plasmid of expected size 4.7 kb. 
 
Transformation into E.coli competent cells 
 
 DpnI digested site-directed mutagenesis PCR product containing wild type Cp3GT and 
mutant P145T with thrombin cleavage site was transformed into E.coli competent cells 
(InvitrogenTM) using heat shock method. Two tubes containing 50µL of competent cells were 
thawed on ice and 25µL of each was transferred to a different sterile Eppendorf tube. A 2µL 
aliquot of DpnI digested wildtype Cp3GT and mutant P145T plasmid with thrombin cleavage 
site was added in each tube and mixed gently (not by pipetting up and down). The tubes were 
incubated on ice for 30 minutes. Low Salt LB agar plates containing zeocin at a concentration of 
25 µg/mL were made at the meantime and 42ºC water bath was made ready for transformation. 
The tubes were subjected to heat shock by transferring to a pre-heated 42oC water bath for 30 
seconds followed by incubation on ice for 2 minutes. A 250µL of S.O.C media (Invitrogen) was 
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added to each tubes and incubated at 37oC shaker for 1 hour at 250rpm. A 50µL and 100 µL of 
this transformed product was spreaded on different LB agar plates and incubated at 37oC 
overnight. 
PCR screening of positive transformants 
 
 A total of seven colonies were selected for each wild type Cp3GT and mutant P145T 
with thrombin cleavage site and resuspended in PCR tubes containing 10 µL sterilized dH2O. A 
5 µL aliquot of the mixture was used as the template for colony PCR to identify positive 
transformants and the remaining mixture was kept at 4oC. PCR reaction were run using the 
conditions shown on Table 4. 
The PCR reaction was run using AOX primers (Table 3). The reactions contained: 
1 µL of AOX1-5’forward primer (1µM)  
1 µL of AOX1-3’reverse primer (1µM)  
5µL of 2X GoTaqR green master mix (Promega) 
 
Table B. 3 AOX primer sequence used for colony PCR  
 
 
Table B. 4 Colony PCR reaction conditions to identify the positive transformants.  
Step Temperature(°C) Time (s) Cycles 
Initiation 94 300 1 
Denaturation 94 30 30 
Annealing 58 30 
Elongation 72 90 
Final elongation 72 300 1 
 
Primer Sequence Tm (°C) 
5’ AOX1 5’-GACTGGTTCCAATTGACAAGC-3’ 54.3 
3’ AOX1 5’-GCAAATGGCATTCTGACATCC-3’ 54.8 
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The PCR products were electrophoresed on a 0.8% agarose gel (Fig. 2.18). Expected size of 
1.7kb was obtained for all the colonies tested.  
Re-streaking of positive transformants 
 
Three different positive transformants each of wild type Cp3GT and mutant P145T with 
thrombin site was selected and re-streaked on six different LB agar plates containing 25µg/mL of 
zeocin and incubated at 37 °C overnight (3 plates each for wild type Cp3GT and mutant P145T). 
One colony from each plates was selected and PCR screening was repeated for the re-streaked 
positive colonies as described. Bands of size 1.7kb was obtained for each colonies tested (Fig. 
2.11). 
Miniprep plasmid extraction for sequencing 
 
Three positive colonies from PCR screening each of wild type Cp3GT and mutant P145T 
with thrombin cleavage site were selected for further Miniprep plasmid extraction. A 5µL aliquot 
of the PCR product of the positive colonies were inoculated into 4mL of LB media containing 
zeocin at a concentration of 25µg/mL and incubated at 37oC overnight at 225rpm. 500µL of 40% 
glycerol and 500µL of each of the PCR product inoculated for plasmid extraction were mixed 
and the tubes were kept in -80oC. 
 GeneJET plasmid mini-prep kit was used for mini-prep plasmid extraction 
(https://tools.thermofisher.com/content/sfs/manuals/MAN0012655_GeneJET_Plasmid_Miniprep
_UG.pdf , Thermo scientific). As directed on the user manual, RNAase was mixed to the 
Resuspension solution and kept at 4oC. A 4.3 mL volume of ethanol was added to the Wash 
solution. A 1.5mL volume of the bacterial cells grown overnight were harvested by centrifuging 
at 8000rpm for 2 min at room temperature. The supernatant was discarded and again 1.5mL of 
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bacterial cells were added and centrifuged and supernatant was discarded. A 500 µL volume of 
the bacterial cells were used to make glycerol stocks and stored at -80oC. Cell pellets were 
resuspended in 250µL of Resuspension solution. Vortexing was done to resuspend the cells 
completely.  A 250µL volume of the Lysis solution was added and mixed thoroughly by 
inverting the tube up and down for 4-5 times. The solution then became viscous and slightly 
clear. At this stage, vortexing was completely avoided to prevent the shearing of the 
chromosomal DNA. A 300µL volume of Neutralization solution was added and mixed 
immediately and thoroughly by inverting the tubes 4-6 times. It is always important to mix 
thoroughly and gently after the addition of the Neutralization solution to avoid localized 
precipitation of bacterial cell debris. The neutralized bacterial lysate should become cloudy. 
Then it was centrifuged for 5 min at 13000 rpm to pellet the cell debris and chromosomal DNA. 
Then the supernatant was transferred to the GeneJet spin column by pipetting. Transferring of 
the white precipitate was completely avoided. Then the spin column was centrifuged for 1 
minute at 13000 rpm. The flow through was discarded and the column was kept back to the same 
tube. A 500µL of wash solution was added to the column and centrifuged for 1 minute at 
13000rpm. Again the flow through was discarded and again the column was centrifuged to avoid 
residual ethanol in plasmid preparation. The GeneJet spin column was transferred to a sterile 
1.5mL centrifuge tube and 50µL of Elution buffer was added to the center of the spin column 
membrane to elute the plasmid DNA. It was incubated for 3 minutes at room temperature. The 
samples were then centrifuged for 2 min and again 50µL of Elution buffer was added and 
centrifuged for 2 minutes. The concentration of DNA was measured using Nanodrop at 260nm. 
The concentration of DNA obtained for four different samples are shown in Table below: 
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Table B. 5  Miniprep Plasmid Extraction. Concentration of DNA after Miniprep extraction of 
four different colonies of wild type Cp3GT and mutant P145T with thrombin cleavage site. 
 
 
 
Four different samples P1, P3, W1 and W3 were sent to Molecular Biology core facility 
of University of Tennessee, Knoxville for sequencing (At least 3µg of DNA is required by UT, 
Knoxville for sequencing). AOX primers and gene specific internal primers were also send for 
sequencing. The samples were sent as following: 
Table B. 6 Samples sent for sequencing. Concentration and volume of samples sent for 
sequencing. 
 
 
 
The sequencing results were analyzed with the Bioedit software and the presence of 
thrombin cleavage site within the frame confirmed. Sample P3 and W3 showed the residues 
within the frame (Fig. 5).  Therefore P3 and W3 were used for further analysis.  
Midiprep plasmid extraction for transformation into yeast 
 
 Wizard plus Midipreps DNA purification System (Promega) was used for midiprep DNA 
extraction and purification 
(https://www.promega.com/~/media/files/resources/protocols/technical%20bulletins/0/wizard%2
0plus%20midipreps%20dna%20purification%20system%20protocol.pdf). Glycerol stock of 
Recombinant mutant with 
thrombin cleavage site  
Sample Concentration (ng/µL) 
P145T P1            102.5 
P3            82.3 
WT W1            77.3 
W3            70.9 
Sample name Conc. (µg/µL) Volume(µL) Total DNA (~µg) 
P1 0.1 50 5 
P3 0.08 50 4.1 
W1 0.077 50 3.8 
W3 0.07 50 3.5 
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E.coli cells containing wild type Cp3GT and mutant P145T with thrombin cleavage site from -
80oC was inoculated in 4mL of LB media containing zeocin at a concentration of 25µg/mL and 
incubated at 37oC shaker overnight at 250rpm.  A 100µL of overnight culture was transferred to 
50mL of LB media containing zeocin at a concentration of 25µg/mL and incubated at 37oC 
overnight at 250rpm. A 40mL volume of overnight culture was centrifuged at 10,000 x g for 10 
minutes at 4oC. The supernatant was poured our off and the tube was blotted upside-down on a 
paper towel to remove excess media. The cell pellets were resuspend in 3mL of Resuspension 
solution completely by vortexing. A 3mL volume of Cell lysis solution was added to the tube 
and mixed well by inverting the tube upside down 4-5 times. A 3mL volume of Neutralization 
solution was added and mixed by inverting the tubes upside down for 4-5 times. The tubes were 
centrifuged at 14,000 x g for 15 minutes at 4oC. Then the supernatant was decanted carefully 
transferred to a different tube avoiding white precipitate.  
A 10ml volume of Wizard® Midipreps DNA Purification Resin was added to the tubes 
and swirled to mix well. Each Midicolumn tip was inserted into the vacuum manifold port and 
the resin/DNA mixture into the Midicolumn. A vacuum of at least 15 inches of Hg was applied 
to pull the resin/DNA mix into the Midicolumn. When all of the sample passed through the 
column, 15 mL of Column wash solution was added to the Midicolumn and vacuum was applied 
to draw the solution through the Midicolumn. After washing off completely, another 15mL of 
Column wash solution was added to the Midicolumn and vacuum was applied again to draw the 
solution through the Midicolumn. In the meantime, nuclease free H2O was pre-heated at 65
oC 
water bath.  
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The Midicolumn was removed from the vacuum port and the lower tip of the Midicolumn 
was cut as described in the protocol. After cutting the Midicolumn, it was transferred to a 1.5ml 
microcentrifuge tube. The Midicolumn was centrifuged at 10,000 × g in a microcentrifuge tube 
for 2 minutes to remove any residual Column Wash Solution. The Midicolumn was transferred 
again to a new microcentrifuge tube. A 300µl volume of preheated (65–70°C) Nuclease-Free 
Water was added to the Midicolumn and incubated for 1 minute. The DNA was eluted by 
centrifuging the Midicolumn at 10,000 × g for 20 seconds in a microcentrifuge. The Midicolumn 
was transferred to a different microcentrifuge tube and added 300µl of Nuclease-Free Water and 
centrifuged the sample at 10,000 × g in a microcentrifuge for 5 minutes to pellet the fines. The 
DNA-containing supernatant was carefully transferred to a clean microcentrifuge tube and the 
concentration of each sample was determined using a Nanodrop at 260nm. The concentration of 
the samples are shown in table below.  
Table B. 7   Midiprep plasmid extraction and purification. Concentration of wild type Cp3GT 
and mutant P145T having thrombin cleavage site after midiprep extraction.  
 
 
 
 
 
Linearization using SacI for transformation in to yeast 
 
 The plasmid containing wild type Cp3GT and mutant P145T having thrombin cleavage 
site was linearized by restriction enzyme SacI (Promega) for efficient transformation into yeast. 
The plasmid DNA extracted by midiprep at a concentration of 5-10µg was used for linearization. 
The reaction mixture consisted of the followings: 
Sample Concentration 
(ng/µL)  
P3-a (P145T)  154.85 
P3-b (P145T)  176.95 
W3-a (Cp3GT)  174.3 
W3-b (Cp3GT)  139.3 
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P145T plasmid 
 
Midiprep plasmid DNA-  100µL 
10X Buffer J-    34µL 
100X BSA-    3µL 
SacI-     3µL 
Sterile H2O-   200µL 
Total volume-    340µL 
 
Cp3GT plasmid 
Midiprep plasmid DNA-  70µL 
10X Buffer J-    34µL 
100X BSA-    3µL 
SacI-     3µL 
Sterile H2O-   230µL 
Total volume-    340µL 
 
A 1.5µL aliquot of SacI enzyme was first added to the reaction mixture containing 
plasmid DNA, 10X Buffer J, 100X BSA and sterile water. The mixture was incubated at 37oC 
water bath for 4 hours and additional 1.5µL of SacI was added further and incubated overnight. 
A 1µL aliquot of the digested sample as well as 1µL aliquot of undigested plasmid DNA was 
mixed with 4µL of sterile water and 1µL of 6X dye and run through 0.8% agarose gel to ensure 
the complete digestion (Fig. 2.10). The reaction was then stopped by incubating the reaction 
mixture in a 65oC water bath to heat inactivate the SacI enzyme.  
Phenol-chloroform extraction of linearized plasmid DNA 
 
A 250µL volume of the linearized DNA was taken for phenol-chloroform extraction to 
purify and concentrate the DNA for transformation into yeast. A 250µL volume of cold phenol-
chloroform-isoamyl alcohol solution was added (1:1 volume ratio) to the linearized DNA sample 
and the mixture was vortexed for 30 seconds and centrifuged at 13000rpm for 1 minute. The 
volume of upper aqueous phase was measured and transferred to a different microcentrifuge 
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tube.  
Volume of P145T plasmid with thrombin site- 200µL 
Volume of Cp3GT plasmid with thrombin site- 200L 
A 1/10 volume of sterile 3M sodium acetate was added to each sample. A 20µL volume 
of 3M sodium acetate was added to each sample. The final volume of the sample was 220µL. To 
this, 2.5 times the volume of ice cold ethanol was added to the final volume of the samples 
(220µL x 2.5 = 550µL of 100% ethanol). The samples were then incubated at -80oC for 1 hour 
followed by centrifugation at 14,000rpm for 15 minutes at 4oC. The supernatant was carefully 
decanted and the DNA pellet was washed with 250µL of 80% ice cold ethanol and centrifuged at 
14,000rpm for 10 minutes at 4oC. The supernatant was carefully poured off and the tubes were 
dried by inverting the tubes over a Kimwipe. The pellets were dissolved in 20µL of sterile water 
and tubes were vortexed and centrifuged for 20 seconds to spin down the DNA. 1µL of the 
purified DNA was resuspended in 19µL of sterile water and concentration was measured using 
Nanodrop at 260nm. The concentration of different samples after phenol-chloroform extraction 
is shown in the table B.8.  
Table B. 8  Phenol chloroform extraction. Concentration of phenol-chloroform extracted wild 
type Cp3GT and mutant P145T plasmid having thrombin cleavage site. 
 
 
 
Competent cell preparation for transformation of DNA into yeast 
 
A starter X-33 Mut+ yeast cells stored at -80oC was inoculated into a 3mL YPD media 
and incubated at 30oC for 22 hours at 250rpm. A 200µL of overnight culture was transferred to 
Sample Concentration ng/µL   
 
P3-a (P145T) 2033.0 
W3-b (Cp3GT) 2722.7 
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200mL of YPD media in a 1L flask and incubated overnight at 30oC at 250rpm. The cells were 
grown to an OD600 of 1.3-1.4. The overnight culture was transferred to 4 different 50mL 
centrifuge tubes and centrifuged for at 2,000 x g for 5 minutes at 4oC. The supernatant was 
poured off and the cell pellets were resuspended in 200mL of ice cold sterile water and 
centrifuged to wash off the pellet. The pellets were again resuspended in 8mL of ice cold 1M 
sorbitol and centrifuged at 2000 x g for 5 minutes at 4oC. The supernatant was poured off and 
the cell pellets were again resuspended in 400µL of ice cold 1M sorbitol and transferred to sterile 
2mL microcentrifuge tubes placed on ice. Electroporation cuvettes (Bio-rad) were placed on ice. 
An 80µL volume of the yeast cells was mixed with 1µg of the purified DNA.  In a separate 
microcentrifuge tube incubated on ice. The mixture was transferred to Electroporation cuvettes 
placed on ice and incubated on ice for 5 minutes. The mixture was pulsed at 1.5kV in the 
Electroporation cuvettes using the Bio-Rad micro pulserTM using setting for Pichia pastoris. A 1 
mL aliquot of ice cold sorbitol was added immediately to the cuvettes and the entire contents 
were transferred to a 15mL sterile glass tube and incubated at 30oC incubator for 90 minutes 
without shaking. Aliquots of 25µL, 50µL, 75µL, and 100µL of the transformed cells were 
spreaded on YPDS plates containing 100µg/mL of zeocin. The plates were incubated at 28oC for 
48-72 hours. Colonies were seen after 48 hours of incubation. Three colonies from each plate 
were re-streaked in YPDS plates and incubated at 28oC for 72 hours.  
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APPENDIX C: SUPPLEMENTARY FIGURES 
 
  
 Fig. C. 1 Multiple sequence alignment of wild type Cp3GT and VvGT using Biodedit.  
The base pairs highlighted with yellow shows the only amino acid difference between the wild 
type Cp3GT and mutant P145. Cytosine is substituted to Adenosine.  
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Insertion of thrombin site 
         
Fig. C. 2 Electrophoresis of site directed mutagenesis PCR product.  
Agarose gel electrophoresis of site-directed mutagenesis PCR product to insert thrombin 
cleavage site in to the wild type Cp3GT and mutant P4145T in between the enzyme and C-myc 
tags. L- 1kb DNA ladder, M1 and M2- mutant P145T, W1 and W2- Wild type Cp3GT.  
                        
      
 
 
  
 
 
 
 
 
Fig. C. 3 DpnI digestion of site-directed PCR product to insert thrombin site.  
Agarose gel electrophoresis of DpnI digested product of site-directed mutagenesis PCR having 
thrombin cleavage site in between the enzyme and C-myc tags. L- 1kb DNA ladder, P1 and P2- 
mutant P145T, W2 and W2- Wild type Cp3GT. 
 
    L            P1        P2         W2        
10kb 
5kb 
4kb 
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